Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AC134980.5 ENSG00000285472 15 22015233-22095857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Approved Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.3 ENSG00000279408 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;testis: 2.2" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 AC171558.1 ENSG00000274792 Unmapped 386278-387620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "testis: 1.6" "Group enriched" "Detected in some" 11 "NTERA-2: 1.0;U-2 OS: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRB2 BAI2 ENSG00000121753 "Adhesion G protein-coupled receptor B2" O60241 1 31727117-31764893 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 52.0" "Cell line enhanced" "Detected in many" "HeLa: 20.5;SH-SY5Y: 15.0;T-47d: 17.3;U-2 OS: 16.9" "Cancer enhanced" "Detected in many" "glioma: 20.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052612, HPA054617" Enhanced Centrosome 49000 Centrosome "HPA052612: , HPA054617: " "prognostic favourable (6.46e-4)" "unprognostic (1.74e-1)" "unprognostic (7.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.90e-1)" "unprognostic (2.40e-1)" "unprognostic (8.17e-4)" "prognostic unfavourable (4.02e-5)" "unprognostic (2.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-3)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (1.75e-3)" "unprognostic (7.98e-2)" 2.2 5.4 15.9 1.3 26.8 1.1 1.4 7.9 52.0 2.4 1.4 7.3 0.0 5.2 2.4 1.2 1.6 2.2 2.1 2.8 18.9 8.0 1.4 0.9 1.3 1.3 7.4 16.5 1.8 1.4 1.3 2.7 3.8 8.4 2.4 1.1 1.3 1.4 3.1 1.1 1.5 5.0 2.4 2.9 1.8 1.8 3.2 6.3 1.5 3.2 0.0 1.1 2.0 0.5 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.5 4.4 4.1 11.9 1.2 0.7 2.0 2.8 4.5 2.7 4.9 0.2 1.3 0.0 2.8 1.2 0.4 1.8 0.2 0.4 3.1 1.8 0.0 20.5 0.0 0.1 0.0 1.5 0.7 0.3 3.8 0.0 0.4 0.4 0.1 3.0 0.4 7.8 0.1 5.1 1.3 11.9 0.4 0.4 0.0 5.6 3.1 15.0 6.4 0.4 0.5 17.3 0.0 0.1 2.1 16.9 0.3 0.7 0.0 0.0 0.4 6.6 0.0 5.0 0.0 0.0 0.0 0.9 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 15.9 26.8 7.9 37.6 18.9 8.0 7.4 16.5 8.4 6.3 ADPGK "ADP-GK, DKFZp434B195" ENSG00000159322 "ADP dependent glucokinase" Q9BRR6 15 72751369-72785846 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045194, HPA058525" Approved Approved Centrosome "Intracellular and membrane" 35000 Centrosome "HPA045194: AB_10964638, HPA058525: " "unprognostic (5.96e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (8.50e-2)" "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (2.22e-4)" "prognostic unfavourable (4.52e-7)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.07e-2)" 15.3 13.5 6.7 16.4 10.7 23.1 13.2 7.8 11.7 10.2 11.3 14.9 11.2 8.9 9.5 14.3 11.1 11.0 12.0 9.3 7.0 9.0 13.3 12.8 18.7 19.8 11.7 6.3 10.7 15.2 4.9 9.1 18.2 13.4 14.2 13.7 20.4 15.8 9.8 7.5 10.9 13.1 8.9 9.8 21.4 10.5 10.7 8.8 19.6 12.0 7.8 21.2 12.3 9.6 14.2 32.0 22.2 30.3 13.8 13.0 22.6 6.6 14.0 7.5 8.8 17.0 12.9 10.1 19.6 19.1 20.5 28.5 7.9 17.7 12.7 14.6 12.2 18.2 21.2 10.2 15.4 12.4 14.5 9.4 4.1 7.4 10.9 21.7 14.1 14.0 6.0 10.8 10.1 11.9 9.9 21.7 12.4 4.2 6.7 9.7 11.1 6.6 7.9 12.2 17.5 10.6 7.8 5.4 5.6 17.9 7.4 9.4 7.1 26.3 9.7 10.3 8.6 39.0 17.7 22.0 41.9 12.6 18.1 21.4 17.1 22.2 30.3 21.9 10.6 21.0 13.0 14.2 9.7 10.7 32.0 12.5 8.5 9.8 12.0 13.8 17.1 24.4 7.6 22.6 6.7 10.7 7.8 11.7 7.0 9.0 11.7 6.3 13.4 8.8 AGPAT2 "BSCL, LPAAT-beta" ENSG00000169692 "1-acylglycerol-3-phosphate O-acyltransferase 2" O15120 9 136673143-136687423 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 71.5;liver: 63.1" "Cell line enhanced" "Detected in many" "HDLM-2: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019544 Uncertain Approved Centrosome Centrosome "HPA019544: AB_1844646" "unprognostic (3.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.01e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (9.30e-3)" "unprognostic (5.06e-3)" "unprognostic (8.98e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (2.17e-1)" "unprognostic (5.61e-2)" "unprognostic (2.60e-1)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" "unprognostic (2.93e-1)" 71.5 5.3 2.3 8.1 2.2 8.4 35.2 2.0 3.0 7.4 20.2 2.2 5.9 31.3 4.7 7.1 11.7 4.1 15.8 12.4 2.8 2.4 10.9 63.1 12.1 11.1 2.5 2.8 5.3 47.7 2.5 6.2 4.9 2.6 5.5 3.3 8.9 12.9 6.2 9.5 7.0 33.6 4.0 1.9 6.8 11.0 5.2 1.9 5.1 13.4 7.0 8.8 6.6 4.9 7.0 20.3 33.2 28.4 2.1 2.5 9.8 14.6 20.6 2.4 11.4 17.7 5.5 10.4 9.7 7.7 6.7 5.1 23.3 29.0 4.8 21.9 5.5 39.7 3.4 6.0 0.7 50.0 15.8 7.1 8.5 5.1 12.2 7.5 17.5 5.3 8.4 5.7 3.0 3.4 8.6 0.8 2.8 26.4 0.5 23.3 6.2 37.5 10.9 8.8 26.6 7.8 9.3 5.5 8.8 12.6 13.3 15.9 8.4 29.5 6.8 8.9 9.1 2.8 6.2 1.2 0.1 3.1 0.1 16.1 8.8 6.0 28.4 33.2 2.2 25.3 2.1 4.1 1.9 2.5 14.9 7.0 1.6 1.8 19.1 2.1 22.2 20.3 2.3 9.8 2.3 2.2 2.0 3.0 2.8 2.4 2.5 2.8 2.6 1.9 AHI1 "FLJ20069, JBTS3, ORF1" ENSG00000135541 "Abelson helper integration site 1" Q8N157 6 135283532-135497776 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation" "Developmental protein" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 54.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031698, HPA046684" Approved Approved Centrosome Centrosome "HPA031698: , HPA046684: " "unprognostic (4.00e-2)" "unprognostic (2.86e-1)" "unprognostic (8.13e-2)" "unprognostic (1.02e-1)" "unprognostic (3.17e-2)" "unprognostic (2.18e-2)" "unprognostic (2.70e-3)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (4.58e-2)" "prognostic favourable (7.51e-5)" "unprognostic (2.81e-2)" "prognostic unfavourable (4.07e-9)" "unprognostic (2.49e-2)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" "unprognostic (6.19e-3)" 6.7 16.2 16.8 6.4 16.5 5.9 12.5 35.3 26.5 11.7 8.7 4.2 13.2 4.9 14.4 32.1 7.8 9.0 9.0 7.6 15.9 19.9 8.4 6.8 8.1 6.0 11.4 19.6 13.9 11.6 11.5 54.2 8.3 18.2 16.3 13.1 10.0 8.2 15.9 6.7 6.1 5.7 11.1 18.5 4.3 10.7 29.2 13.1 3.3 11.6 5.0 6.3 8.9 12.0 10.6 16.6 4.8 1.7 3.8 4.2 0.5 5.2 7.1 8.4 10.8 13.7 14.9 3.7 9.6 12.1 9.7 14.9 2.7 5.6 8.1 4.7 9.3 4.0 6.3 3.0 14.5 6.4 8.4 2.9 20.2 5.2 5.9 15.1 3.3 7.0 4.9 15.0 8.2 8.0 13.4 0.5 13.1 5.5 14.3 3.4 5.0 4.4 7.2 3.4 2.7 4.9 5.2 14.6 7.8 12.8 4.7 5.7 3.8 6.8 7.5 8.4 10.4 14.4 7.5 10.6 9.8 3.8 11.9 2.2 10.0 4.8 1.7 0.6 4.2 0.5 2.6 8.2 4.0 4.2 2.6 10.6 3.2 4.1 0.1 3.8 0.5 16.6 2.4 0.5 16.8 16.5 35.3 26.5 15.9 19.9 11.4 19.6 18.2 13.1 ALDH8A1 ALDH12 ENSG00000118514 "Aldehyde dehydrogenase 8 family member A1" Q9H2A2 6 134917390-134950122 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 26.2;liver: 90.1" "Cell line enhanced" "Detected in many" "HEK 293: 5.5;RPTEC TERT1: 6.3" "Group enriched" "Detected in some" 7 "liver cancer: 26.3;renal cancer: 17.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026292, HPA055414" Enhanced Supported Centrosome 24000 Centrosome "HPA026292: AB_1844741, HPA055414: AB_2682810" "unprognostic (1.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "unprognostic (1.75e-1)" "unprognostic (2.70e-2)" "unprognostic (6.32e-2)" "unprognostic (4.30e-3)" "unprognostic (1.12e-1)" "unprognostic (3.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "prognostic favourable (9.87e-4)" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (2.36e-2)" "unprognostic (5.86e-5)" 0.3 0.3 0.8 0.3 1.0 0.6 0.3 1.9 0.9 0.3 0.6 0.3 0.3 0.2 0.3 0.6 0.3 0.1 0.3 0.3 1.4 0.6 26.2 90.1 0.3 0.3 1.1 0.4 0.3 0.3 0.2 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.8 0.3 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.3 1.5 1.1 5.9 0.9 2.3 1.3 0.6 0.2 1.0 1.5 0.8 0.5 0.2 1.4 0.4 0.5 0.1 0.9 0.5 0.7 0.4 0.5 0.0 1.1 1.1 0.0 0.8 1.2 5.5 3.6 3.8 5.2 0.6 1.4 2.0 1.5 1.8 0.4 0.9 0.4 5.3 2.2 0.2 0.0 1.7 2.3 0.3 1.1 0.1 0.5 0.5 6.3 0.8 1.6 0.5 0.3 0.1 1.3 0.9 0.3 0.4 0.8 3.1 1.2 1.5 5.5 1.7 0.9 0.7 1.4 0.5 5.9 0.9 0.9 1.3 0.3 0.5 1.0 1.2 0.7 0.1 1.5 1.1 0.9 2.4 2.3 0.4 1.1 1.2 0.6 0.8 1.0 1.9 0.9 1.4 0.6 1.1 0.4 0.3 0.3 ALPK1 "FLJ22670, KIAA1527, Lak" ENSG00000073331 "Alpha kinase 1" Q96QP1 4 112285509-112442620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027435, HPA027443" Approved Approved Centrosome Centrosome "HPA027435: AB_10599614, HPA027443: AB_10599421" "unprognostic (6.24e-2)" "unprognostic (1.92e-1)" "unprognostic (9.30e-2)" "unprognostic (1.69e-2)" "unprognostic (7.40e-2)" "unprognostic (5.45e-2)" "unprognostic (2.55e-2)" "unprognostic (7.47e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (7.14e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (5.82e-7)" "unprognostic (1.60e-1)" "unprognostic (4.17e-2)" "unprognostic (2.81e-1)" "prognostic favourable (1.17e-4)" 15.1 10.6 5.3 8.3 7.7 17.3 9.3 1.3 5.9 10.8 9.5 5.8 3.0 4.5 9.8 9.2 8.8 9.2 7.5 6.1 6.1 2.3 10.8 13.4 13.2 11.4 9.7 1.0 17.4 9.7 11.0 14.0 11.5 6.6 14.0 7.8 9.6 10.4 6.8 5.0 11.8 12.1 11.3 16.6 16.2 7.4 4.2 8.5 13.7 12.4 4.7 13.7 13.6 11.6 0.9 3.2 16.3 4.3 0.4 0.8 1.2 1.6 5.0 1.5 0.3 6.5 10.4 2.0 1.9 3.4 2.6 3.2 0.5 7.6 5.0 3.3 3.2 1.1 1.7 3.0 3.8 6.4 1.7 3.6 2.0 0.4 10.5 2.2 2.2 12.9 8.5 3.7 7.8 1.0 0.9 8.8 4.9 3.0 1.2 2.0 0.4 1.2 0.6 1.1 1.6 3.8 1.8 0.5 0.8 1.8 6.5 2.8 2.9 4.0 1.9 2.3 2.1 3.7 1.2 2.2 0.7 4.3 5.7 4.5 2.1 1.3 3.2 1.4 0.2 4.3 0.6 0.8 0.6 0.1 3.2 0.9 0.8 0.6 16.3 0.4 1.9 0.5 0.0 1.2 5.3 7.7 1.3 5.9 6.1 2.3 9.7 1.0 6.6 8.5 AMN1 ENSG00000151743 "Antagonist of mitotic exit network 1 homolog" Q8IY45 12 31671137-31729174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046157, HPA062290" Approved Approved Centrosome Centrosome "HPA046157: AB_10965846, HPA062290: " "unprognostic (2.11e-2)" "unprognostic (2.52e-1)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "unprognostic (2.80e-1)" "unprognostic (5.93e-2)" "unprognostic (8.60e-3)" "unprognostic (4.08e-2)" "unprognostic (6.48e-2)" "unprognostic (3.01e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-2)" "unprognostic (2.48e-1)" "unprognostic (4.74e-2)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" 5.3 9.9 24.8 6.1 20.9 3.1 9.0 13.8 28.3 9.6 4.3 11.1 2.9 3.8 10.8 7.9 6.0 17.0 6.9 10.1 22.4 20.9 11.3 5.8 6.5 10.3 19.6 15.2 16.0 8.2 8.5 16.1 5.4 14.8 8.9 4.3 8.9 5.9 7.8 12.8 5.4 4.1 7.3 19.4 8.4 8.4 46.5 16.2 11.7 7.9 4.2 9.0 7.7 5.5 12.3 6.6 27.4 2.7 4.7 9.8 3.4 4.0 8.8 7.2 0.8 7.0 9.0 4.2 4.2 6.6 3.0 5.8 4.6 16.1 2.0 9.7 3.7 2.3 3.3 5.1 6.1 3.4 4.3 7.0 3.2 6.5 12.6 3.7 3.7 6.0 8.3 5.1 7.3 17.0 6.1 6.7 11.4 2.5 2.1 3.0 9.9 4.3 3.1 11.6 3.3 6.9 9.1 11.6 9.6 5.6 1.5 8.8 13.5 4.2 9.5 5.1 4.2 4.2 7.7 7.3 6.9 7.2 6.4 3.5 9.5 4.3 2.7 3.3 4.3 1.9 4.3 12.3 4.5 4.6 2.1 11.5 9.8 5.9 27.4 4.7 1.6 6.6 6.7 3.4 24.8 20.9 13.8 28.3 22.4 20.9 19.6 15.2 14.8 16.2 ATG5 "APG5, APG5L, ASP, hAPG5" ENSG00000057663 "Autophagy related 5" Q9H1Y0 6 106045423-106325791 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Host-virus interaction, Immunity" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034432, CAB037309, HPA042973" Approved Approved Centrosome "Intracellular and membrane" Centrosome "CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246" "unprognostic (1.21e-3)" "unprognostic (6.53e-3)" "unprognostic (2.68e-3)" "unprognostic (4.14e-1)" "unprognostic (1.13e-1)" "unprognostic (6.35e-3)" "prognostic unfavourable (8.84e-4)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.86e-1)" "unprognostic (2.37e-1)" "unprognostic (2.51e-1)" "unprognostic (6.42e-2)" 18.0 28.5 16.1 15.6 17.2 9.4 21.4 16.0 21.4 23.0 20.9 10.5 14.1 16.9 21.5 23.2 16.7 20.6 12.8 14.0 15.1 15.4 20.5 23.6 15.4 18.1 14.7 15.8 21.0 16.7 12.8 23.3 26.9 17.0 22.9 20.6 11.0 16.5 21.7 20.4 10.9 28.6 19.7 14.9 20.3 16.4 13.0 10.2 23.3 24.9 14.7 18.0 20.7 21.0 7.3 6.8 11.6 10.5 6.5 12.9 4.9 8.2 3.6 6.0 8.1 13.9 15.0 6.3 8.8 14.1 13.0 16.0 3.5 5.0 5.8 7.1 13.4 5.9 8.7 12.9 23.0 2.5 4.9 6.8 4.5 4.4 14.9 8.0 3.5 11.6 14.4 9.3 11.8 13.7 9.7 5.8 14.7 3.7 3.3 9.7 6.9 4.9 3.4 14.2 4.5 14.0 5.9 4.6 4.3 5.4 10.2 8.0 5.0 15.5 11.3 5.1 2.9 5.9 15.0 2.4 2.3 5.4 18.9 11.0 9.2 5.1 6.5 11.6 4.8 7.7 12.9 7.3 8.5 6.6 6.8 5.2 9.3 7.9 5.5 6.5 10.5 2.6 9.0 4.9 16.1 17.2 16.0 21.4 15.1 15.4 14.7 15.8 17.0 10.2 AUNIP "AIBp, C1orf135, MGC2603" ENSG00000127423 "Aurora kinase A and ninein interacting protein" Q9H7T9 1 25831913-25859458 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 35.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028730 Uncertain Supported Centrosome Centrosome "HPA028730: AB_10670830" "unprognostic (8.05e-2)" "unprognostic (1.98e-2)" "unprognostic (3.96e-3)" "prognostic unfavourable (3.94e-4)" "unprognostic (9.51e-2)" "unprognostic (8.86e-2)" "unprognostic (9.70e-6)" "unprognostic (5.00e-3)" "unprognostic (9.06e-3)" "unprognostic (4.59e-3)" "unprognostic (1.42e-3)" "unprognostic (1.12e-2)" "unprognostic (1.01e-6)" "unprognostic (3.61e-2)" "unprognostic (4.41e-2)" "unprognostic (4.70e-2)" "unprognostic (3.62e-1)" 0.4 1.6 2.5 3.4 1.4 7.2 0.6 2.1 4.0 0.5 1.1 0.2 0.1 1.3 0.5 0.8 2.1 0.5 0.4 0.8 2.8 0.9 0.6 0.8 0.6 1.6 0.9 1.4 0.5 0.5 0.2 0.7 7.0 2.6 0.6 1.3 0.0 0.6 1.7 0.9 0.8 1.1 0.5 0.5 1.2 0.8 35.3 0.0 5.3 0.5 3.2 2.3 0.9 0.9 1.4 2.0 4.4 3.5 1.5 2.3 1.1 11.5 3.3 5.3 6.7 0.2 0.4 5.2 6.7 3.1 13.4 11.0 2.8 8.9 11.5 5.1 2.3 9.4 14.3 6.5 10.8 6.4 11.5 25.2 5.4 4.3 0.1 12.2 11.1 0.3 3.3 8.2 5.7 3.0 15.5 5.7 3.7 6.3 8.9 10.4 9.4 4.2 7.3 10.4 7.1 4.1 3.8 7.7 3.6 9.3 10.5 7.3 3.8 6.3 1.2 3.9 6.1 8.1 5.9 2.2 4.5 8.6 2.7 20.6 6.3 4.4 2.5 1.7 0.6 3.5 0.4 0.9 1.0 0.8 2.0 1.4 0.9 1.3 2.2 1.5 2.1 1.6 2.3 1.1 2.5 1.4 2.1 4.0 2.8 0.9 0.9 1.4 2.6 0.0 BRMS1 DKFZP564A063 ENSG00000174744 "Breast cancer metastasis suppressor 1" Q9HCU9 11 66337333-66345125 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010824, HPA019637" Approved Approved Centrosome Centrosome "CAB010824: , HPA019637: AB_1845448" "unprognostic (1.75e-1)" "unprognostic (2.64e-2)" "unprognostic (2.01e-1)" "unprognostic (4.31e-2)" "unprognostic (1.72e-2)" "unprognostic (5.50e-2)" "prognostic unfavourable (6.74e-4)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (5.67e-3)" "unprognostic (2.54e-1)" "unprognostic (6.32e-2)" "unprognostic (1.61e-1)" 17.2 18.9 16.7 23.4 24.5 37.0 20.5 9.1 18.7 13.7 19.7 14.5 24.7 21.0 14.6 21.0 24.1 16.1 26.0 13.7 16.6 10.7 23.4 22.2 16.7 25.8 20.1 16.1 14.0 37.6 17.6 12.6 24.1 17.6 22.3 16.0 12.8 23.9 29.8 24.2 26.1 22.6 13.0 16.2 26.3 19.6 37.4 20.9 25.3 20.8 29.3 21.4 16.2 17.5 38.5 32.1 50.7 38.0 22.2 37.2 28.9 24.2 31.8 10.7 17.9 11.4 11.9 15.2 16.7 18.6 30.7 20.6 25.9 16.0 16.4 25.3 16.6 28.6 20.4 30.9 14.5 19.4 17.0 14.9 17.0 18.8 21.3 21.5 17.5 13.4 33.3 30.9 23.2 18.8 17.7 7.7 18.2 39.1 26.2 51.4 23.2 30.0 22.3 19.7 30.7 19.0 14.1 22.7 18.2 21.0 21.7 54.5 26.4 13.4 18.1 23.1 21.9 37.1 21.0 16.0 15.8 25.9 29.9 14.1 24.7 19.0 38.0 36.7 31.1 36.2 33.2 38.5 33.5 29.6 29.8 36.1 29.7 28.0 50.7 22.2 31.0 32.1 37.2 28.9 16.7 24.5 9.1 18.7 16.6 10.7 20.1 16.1 17.6 20.9 C11orf70 MGC13040 ENSG00000137691 "Chromosome 11 open reading frame 70" Q9BRQ4 11 102047443-102084560 "Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.5;testis: 54.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 16.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038585 Enhanced Approved Centrosome Centrosome "HPA038585: AB_10795357" "unprognostic (9.70e-2)" "unprognostic (3.18e-1)" "unprognostic (3.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.05e-1)" "unprognostic (2.04e-1)" "unprognostic (4.16e-2)" "unprognostic (2.62e-1)" "unprognostic (3.03e-2)" "unprognostic (5.00e-2)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-6)" "unprognostic (1.76e-2)" "unprognostic (8.68e-3)" "unprognostic (2.94e-2)" "unprognostic (6.73e-3)" 2.5 3.7 2.9 1.1 4.2 0.1 3.1 0.7 1.4 5.9 1.6 5.4 11.6 0.8 5.3 11.9 2.3 25.5 4.9 1.7 3.9 4.5 3.0 0.3 7.2 1.2 1.7 1.3 7.5 0.8 3.7 13.7 4.0 16.0 5.6 0.8 4.2 1.1 7.0 0.5 1.6 0.8 5.5 1.9 0.2 1.6 54.7 2.2 0.0 3.3 1.1 0.8 3.8 2.5 0.6 0.3 2.3 0.6 0.3 0.4 0.2 0.0 6.6 6.7 0.0 6.1 14.7 0.2 2.6 6.7 3.6 5.2 0.5 8.6 0.0 1.6 5.1 1.6 1.6 0.8 2.6 0.0 1.0 0.0 1.1 0.0 4.3 0.0 0.0 6.2 8.4 9.4 6.3 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 9.9 1.8 7.4 0.0 8.5 0.1 0.0 7.5 0.0 1.0 0.9 2.8 8.8 2.1 0.1 0.0 0.0 3.0 0.0 0.4 1.6 0.6 0.4 0.3 0.2 0.2 0.5 0.3 0.3 0.1 0.6 0.4 0.3 2.3 0.3 0.2 0.3 0.2 0.2 2.9 4.2 0.7 1.4 3.9 4.5 1.7 1.3 16.0 2.2 C11orf80 "FLJ22531, TOPOVIBL" ENSG00000173715 "Chromosome 11 open reading frame 80" Q8N6T0 11 66744451-66843328 "Predicted intracellular proteins" Meiosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA038932, HPA038933" Approved Approved Centrosome Centrosome "HPA038932: , HPA038933: AB_10671867" "unprognostic (2.81e-1)" "unprognostic (4.39e-2)" "unprognostic (1.71e-2)" "unprognostic (6.69e-2)" "unprognostic (3.30e-1)" "unprognostic (2.09e-1)" "unprognostic (5.54e-3)" "unprognostic (4.16e-1)" "unprognostic (4.26e-2)" "unprognostic (6.59e-2)" "unprognostic (4.04e-2)" "unprognostic (2.53e-2)" "unprognostic (6.31e-2)" "unprognostic (1.23e-1)" "unprognostic (4.98e-1)" "unprognostic (3.72e-2)" "unprognostic (1.26e-1)" 2.8 7.6 15.0 12.9 15.0 4.8 10.3 26.2 11.9 7.1 10.1 1.7 4.7 7.7 5.9 13.3 16.4 5.4 4.6 4.2 8.3 7.2 13.4 2.2 4.4 5.8 5.0 11.9 3.3 4.7 10.9 12.4 3.9 8.0 10.0 9.0 5.5 10.7 9.5 1.3 35.6 17.3 4.2 2.7 6.8 5.1 15.2 2.5 15.1 3.6 7.6 15.3 4.8 8.8 10.6 9.7 3.1 1.0 1.7 4.2 0.7 9.0 4.8 9.9 6.7 0.5 3.2 1.8 3.8 4.6 4.5 5.7 16.7 11.1 14.8 2.2 3.1 16.6 4.6 5.8 4.6 3.7 2.6 2.4 6.0 4.2 1.1 1.6 2.8 0.8 20.1 3.5 6.7 14.4 4.3 5.7 2.7 10.0 5.9 5.3 15.7 6.7 3.5 4.6 11.4 19.7 3.1 7.4 7.4 6.3 17.4 13.4 12.0 1.1 6.3 3.2 5.9 3.4 5.5 4.0 8.8 10.7 3.6 2.9 4.1 1.9 0.9 3.1 2.1 0.5 3.7 10.6 3.8 3.0 0.5 8.9 4.2 3.5 2.3 1.7 1.0 9.7 4.0 0.7 15.0 15.0 26.2 11.9 8.3 7.2 5.0 11.9 8.0 2.5 C2orf74 LOC339804 ENSG00000237651 "Chromosome 2 open reading frame 74" A8MZ97 2 61145068-61164829 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026826 Approved Approved Centrosome Centrosome "HPA026826: AB_10671091" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (4.54e-2)" "unprognostic (8.10e-2)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-3)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (6.65e-2)" "unprognostic (3.52e-1)" "unprognostic (6.22e-2)" 15.8 19.4 32.2 10.7 38.5 2.4 19.1 12.6 33.7 15.4 11.5 13.6 10.0 3.6 12.7 30.2 9.6 13.6 8.6 25.3 25.8 26.1 26.0 22.7 11.4 12.3 26.9 18.4 17.1 8.9 12.5 26.0 11.2 26.0 13.0 6.0 5.8 8.7 12.5 15.0 5.4 5.7 12.7 22.3 13.5 9.9 27.4 22.5 5.7 20.5 12.5 10.1 9.9 10.0 20.1 10.8 17.0 10.4 18.4 20.6 6.8 5.7 10.0 10.4 0.0 22.3 22.8 9.4 15.1 17.4 14.5 12.0 0.0 9.8 7.2 21.1 12.3 7.8 0.0 12.4 24.9 9.1 6.2 0.0 9.5 11.5 9.0 8.6 8.1 23.4 20.4 10.8 22.1 8.0 0.0 5.5 22.1 10.5 0.0 16.5 9.9 6.3 13.0 12.9 12.1 19.8 4.5 21.6 8.3 1.9 1.9 12.6 7.9 8.7 4.2 12.3 5.3 7.3 18.3 23.1 10.5 27.3 16.2 6.2 10.8 9.9 4.9 17.0 11.4 10.4 14.5 20.1 12.5 11.6 10.8 13.0 20.6 16.3 1.1 18.4 10.1 8.9 16.1 6.8 32.2 38.5 12.6 33.7 25.8 26.1 26.9 18.4 26.0 22.5 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42692663-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.2;fallopian tube: 13.6;testis: 15.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.3;Daudi: 1.2;HDLM-2: 2.9;NTERA-2: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA047429 Approved Supported Centrosome Centrosome "HPA047429: " "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.7 1.0 3.0 0.7 12.2 0.6 0.7 0.8 4.0 1.3 0.9 6.3 2.3 1.1 2.1 7.0 0.7 13.6 1.5 1.7 3.7 2.7 1.1 1.7 2.5 0.7 1.9 4.6 1.5 2.0 1.0 3.7 0.7 8.1 0.7 1.4 1.5 1.6 1.1 2.0 0.6 1.1 0.9 3.4 0.8 0.8 15.0 2.5 0.0 1.9 0.3 0.6 0.7 0.5 0.0 0.0 0.1 0.2 0.5 1.2 0.2 0.0 0.0 0.0 1.1 2.3 0.9 0.7 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.1 2.9 0.8 0.0 0.3 0.0 0.0 0.0 0.4 0.6 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 3.0 12.2 0.8 4.0 3.7 2.7 1.9 4.6 8.1 2.5 CCDC14 "DKFZp434L1050, FLJ12892" ENSG00000175455 "Coiled-coil domain containing 14" Q49A88 3 123897305-123961408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035278, HPA035279" Uncertain Enhanced Centrosome Centrosome "HPA035278: , HPA035279: AB_10601253" "unprognostic (7.41e-3)" "unprognostic (5.18e-2)" "unprognostic (1.86e-1)" "unprognostic (1.41e-1)" "unprognostic (9.45e-2)" "prognostic favourable (5.27e-4)" "prognostic unfavourable (4.82e-4)" "unprognostic (6.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.76e-1)" "prognostic unfavourable (4.76e-4)" "prognostic unfavourable (3.50e-8)" "unprognostic (2.14e-2)" "unprognostic (2.86e-1)" "unprognostic (9.37e-2)" "prognostic favourable (2.72e-5)" 11.3 9.7 13.6 22.4 15.2 30.0 19.1 8.0 16.2 14.5 18.8 10.8 7.7 12.0 20.4 31.9 10.2 15.8 14.9 9.1 13.6 8.7 13.3 13.7 14.1 14.3 14.3 13.0 20.6 15.4 7.8 24.4 9.7 14.5 17.2 31.8 9.6 14.3 9.8 5.9 20.2 15.9 13.6 17.4 13.7 12.8 22.5 16.0 36.5 14.0 11.2 13.3 12.7 13.0 2.1 4.5 3.0 2.2 6.0 5.6 1.9 16.5 9.7 30.1 11.9 4.2 6.2 14.1 33.4 11.0 16.2 18.7 7.6 11.9 4.9 8.6 6.9 18.9 10.9 5.5 22.0 4.1 7.7 19.7 17.9 7.1 3.9 12.9 12.7 6.2 3.5 8.4 9.0 7.7 10.2 9.1 11.1 8.2 11.2 6.1 9.0 11.4 19.3 12.5 5.6 9.3 13.6 10.5 12.5 19.6 4.9 12.7 11.7 9.5 10.0 39.2 20.4 12.0 10.8 8.6 6.0 14.8 13.2 9.9 13.6 2.8 1.6 3.0 3.9 2.2 2.6 2.1 3.4 3.3 1.0 2.0 3.8 3.2 0.3 6.0 0.6 4.5 5.6 1.9 13.6 15.2 8.0 16.2 13.6 8.7 14.3 13.0 14.5 16.0 CCNF "FBX1, FBXO1" ENSG00000162063 "Cyclin F" P41002 16 2429394-2458854 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060596, HPA070495, HPA071600" Enhanced Supported Centrosome Centrosome "HPA060596: , HPA070495: AB_2686273, HPA071600: AB_2686424" "unprognostic (3.87e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-3)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "prognostic unfavourable (7.46e-7)" "unprognostic (2.45e-2)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-1)" 2.1 1.8 4.1 6.0 3.2 9.2 5.1 11.6 4.9 2.1 3.0 1.9 3.6 4.4 1.5 3.4 8.1 1.5 1.5 1.8 4.3 3.9 1.7 1.6 2.2 10.5 1.9 3.1 1.8 1.7 0.8 1.8 3.8 2.4 3.0 3.2 0.7 3.2 3.4 2.5 7.2 3.2 1.8 1.7 4.7 2.6 5.1 2.3 35.7 1.6 3.4 14.2 5.0 2.9 2.7 1.4 0.1 1.1 4.1 3.1 1.7 8.3 13.2 12.7 11.6 0.8 1.2 10.0 10.1 5.0 14.1 10.9 26.3 10.3 17.7 3.4 5.7 14.3 21.1 7.8 6.8 12.5 10.0 19.4 13.7 8.0 1.0 12.7 12.7 0.8 1.0 10.0 4.8 10.5 20.6 11.6 7.1 18.2 18.5 8.4 12.6 6.1 31.0 15.0 15.8 3.9 3.7 12.4 7.0 15.1 13.2 2.7 14.0 6.5 7.2 7.8 20.3 5.5 10.5 7.1 8.5 30.6 2.2 12.7 10.6 0.0 1.1 0.0 2.8 0.6 1.7 2.7 1.5 3.1 0.5 2.6 1.2 1.7 0.1 4.1 0.9 1.4 2.2 1.7 4.1 3.2 11.6 4.9 4.3 3.9 1.9 3.1 2.4 2.3 CCP110 "CP110, KIAA0419" ENSG00000103540 "Centriolar coiled-coil protein 110" O43303 16 19523811-19553408 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039402 Approved Supported Centrosome Centrosome "HPA039402: AB_10671041" "unprognostic (2.83e-1)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-1)" "unprognostic (4.88e-2)" "unprognostic (9.68e-2)" "unprognostic (3.25e-2)" "unprognostic (2.68e-1)" "unprognostic (6.50e-2)" "unprognostic (1.92e-2)" "unprognostic (8.99e-3)" "unprognostic (2.74e-2)" "unprognostic (1.82e-1)" "unprognostic (3.01e-2)" "unprognostic (1.37e-1)" 5.2 5.9 19.0 6.0 39.1 12.6 9.0 19.1 28.4 7.6 4.5 13.2 4.6 3.7 8.9 7.3 6.4 13.0 5.7 4.4 23.6 15.0 4.5 3.4 8.1 7.1 40.0 13.3 10.6 3.7 9.6 17.2 4.6 20.6 7.3 5.5 2.1 4.8 7.1 4.3 5.5 4.5 7.6 16.0 5.8 6.1 31.6 36.6 10.9 6.9 1.9 7.1 5.7 6.6 4.5 4.0 13.0 5.3 2.3 5.6 2.5 11.2 5.2 12.9 12.5 6.5 5.8 6.7 12.0 7.0 10.7 12.1 4.2 6.0 16.5 7.6 5.9 7.9 13.2 3.8 18.1 7.5 6.0 8.2 7.2 7.2 3.2 21.1 10.6 2.8 5.3 12.0 7.4 8.2 8.6 8.3 12.5 8.7 21.6 8.2 9.9 3.9 27.6 24.1 5.8 4.9 4.7 25.5 12.9 13.0 6.2 3.9 11.3 12.9 4.8 12.5 8.3 8.4 9.8 9.3 8.6 12.0 8.0 9.1 7.3 13.0 3.8 6.7 5.5 3.6 3.5 3.3 4.9 5.2 4.0 4.5 5.6 3.2 7.7 2.3 5.3 2.6 3.9 2.5 19.0 39.1 19.1 28.4 23.6 15.0 40.0 13.3 20.6 36.6 CEP152 "KIAA0912, MCPH9, SCKL5" ENSG00000103995 "Centrosomal protein 152" O94986 15 48712928-48811146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039408 Approved Supported Centrosome Centrosome "HPA039408: AB_10795288" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.61e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-1)" "unprognostic (3.87e-4)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" "unprognostic (1.04e-2)" "unprognostic (5.82e-2)" "unprognostic (4.70e-3)" "unprognostic (3.47e-2)" "unprognostic (6.24e-3)" "unprognostic (5.29e-2)" "unprognostic (3.55e-1)" "unprognostic (4.60e-2)" "unprognostic (1.25e-1)" 4.0 3.0 3.5 10.1 5.5 21.4 4.8 9.9 10.3 3.7 6.9 0.9 5.4 4.7 3.3 3.4 5.5 3.3 3.0 4.4 4.5 1.5 7.1 2.4 4.4 6.3 3.3 1.6 5.5 6.0 2.4 5.8 9.0 4.7 3.5 5.1 1.8 5.1 6.9 1.7 4.7 7.9 3.3 9.0 6.1 4.1 15.8 4.8 18.4 6.2 2.4 7.1 3.7 7.6 5.3 4.4 6.0 4.1 3.6 3.3 1.4 4.7 3.6 7.5 9.1 1.3 2.5 4.8 8.3 3.5 6.2 7.6 7.8 4.0 10.9 3.6 2.4 11.2 8.4 3.0 9.1 9.6 5.1 17.6 18.5 4.2 0.9 14.7 8.3 0.9 2.4 6.8 4.0 4.5 10.6 13.3 5.2 2.6 10.8 13.8 4.7 3.7 13.3 10.1 13.5 2.2 4.6 9.0 6.0 6.5 5.4 2.5 4.1 7.2 3.6 15.2 8.0 11.7 9.2 5.6 6.2 12.8 4.9 21.5 10.6 4.5 3.2 5.3 2.7 4.1 2.3 2.9 3.0 2.8 2.4 5.3 3.3 3.3 6.0 3.6 4.1 4.4 3.1 1.4 3.5 5.5 9.9 10.3 4.5 1.5 3.3 1.6 4.7 4.8 CEP19 "C3orf34, MGC14126" ENSG00000174007 "Centrosomal protein 19" Q96LK0 3 196706277-196712293 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 12.9;eosinophil: 17.5;neutrophil: 45.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047614, HPA071138" Enhanced Supported Centrosome Centrosome "HPA047614: , HPA071138: " "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (5.11e-2)" "unprognostic (9.31e-2)" "unprognostic (5.51e-3)" "unprognostic (4.66e-2)" "unprognostic (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (2.36e-2)" "unprognostic (1.91e-1)" "unprognostic (3.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.33e-2)" 3.2 5.2 10.2 5.7 11.7 2.4 2.4 7.3 10.8 3.6 2.3 3.0 2.6 2.0 3.3 6.2 3.2 8.0 3.8 2.4 8.4 9.0 5.2 2.3 3.2 5.0 6.5 6.0 3.8 1.4 6.1 9.2 3.9 8.3 3.5 2.2 2.5 2.3 4.4 1.3 3.3 2.0 3.0 4.4 6.1 1.7 17.5 4.4 8.3 5.1 0.4 6.3 4.0 2.6 1.4 3.4 45.3 1.3 2.3 3.5 1.2 5.1 3.6 5.0 3.1 11.6 9.0 1.5 4.2 8.0 4.6 6.0 1.8 3.5 3.9 12.2 2.1 2.3 3.3 1.1 5.5 5.3 3.4 5.9 1.8 0.5 4.7 2.7 7.6 4.1 5.0 6.0 1.6 1.9 3.2 4.8 4.7 2.7 6.6 4.8 2.6 6.1 7.9 3.1 2.7 4.9 0.5 5.0 3.6 5.8 0.8 6.5 4.5 5.2 1.5 5.4 1.2 8.2 2.8 14.8 14.1 8.0 7.6 6.9 5.2 12.9 1.3 17.5 1.8 0.9 2.0 1.1 2.6 2.3 0.8 1.4 3.5 2.2 45.3 2.3 1.0 3.4 1.4 1.2 10.2 11.7 7.3 10.8 8.4 9.0 6.5 6.0 8.3 4.4 CEP250 "C-NAP1, CEP2" ENSG00000126001 "Centrosomal protein 250" Q9BV73 20 35455164-35519280 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064875 Supported Centrosome Centrosome "HPA064875: " "unprognostic (6.35e-2)" "unprognostic (2.94e-1)" "unprognostic (2.31e-1)" "unprognostic (1.21e-3)" "unprognostic (1.99e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (1.77e-7)" "unprognostic (1.60e-1)" "unprognostic (7.81e-2)" "unprognostic (3.47e-2)" "prognostic favourable (9.27e-6)" "unprognostic (1.42e-1)" "prognostic unfavourable (1.97e-6)" "unprognostic (1.30e-1)" "unprognostic (6.40e-2)" "unprognostic (2.90e-3)" "unprognostic (4.57e-2)" 7.2 8.3 15.2 12.9 23.6 20.0 6.3 35.1 19.7 9.9 8.3 12.0 13.1 7.2 11.4 9.8 9.8 12.8 7.7 6.5 10.8 12.7 6.0 5.3 7.3 21.7 10.6 11.3 15.6 7.7 19.0 17.8 6.7 11.5 11.9 8.9 11.2 10.3 9.8 8.8 13.4 9.6 10.3 11.8 17.4 7.9 18.5 14.7 12.2 8.3 6.2 14.1 10.2 9.4 6.0 12.7 14.8 2.2 6.4 10.0 4.0 13.2 15.4 7.5 14.0 11.4 10.4 11.5 6.6 7.3 10.5 8.3 20.6 10.9 14.2 8.9 9.4 14.7 8.1 20.0 11.8 2.6 3.2 26.7 11.5 18.9 6.9 13.0 14.8 7.4 12.2 17.8 25.3 10.7 9.2 13.6 17.8 6.8 15.9 13.2 5.2 17.5 9.3 21.8 3.9 10.0 15.1 10.4 11.3 18.0 12.5 8.6 8.6 11.4 17.2 47.5 12.4 17.6 9.6 4.8 5.2 13.2 25.8 8.8 8.0 14.8 1.7 4.5 10.0 2.2 6.3 5.4 4.3 8.0 3.7 6.0 5.2 5.7 0.7 6.4 1.4 12.7 4.5 4.0 15.2 23.6 35.1 19.7 10.8 12.7 10.6 11.3 11.5 14.7 CEP290 "3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6" ENSG00000198707 "Centrosomal protein 290" O15078 12 88049014-88142216 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" Activator "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB029995, HPA043918, HPA064397" Approved Supported Centrosome Centrosome "CAB029995: , HPA043918: , HPA064397: " "unprognostic (7.42e-2)" "unprognostic (4.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "unprognostic (3.26e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-4)" "unprognostic (2.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.94e-2)" "unprognostic (7.25e-2)" "prognostic unfavourable (3.21e-6)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (2.44e-2)" "unprognostic (3.84e-3)" 7.0 7.7 14.4 15.5 17.2 9.3 9.8 15.2 19.5 10.0 8.1 5.4 7.6 5.2 13.3 11.8 4.9 10.6 7.3 6.4 11.3 10.9 7.9 4.7 7.0 8.2 13.2 13.4 17.7 6.7 21.7 22.4 8.3 12.7 10.4 7.5 4.9 4.8 7.7 4.0 7.0 6.1 8.7 14.0 7.5 7.6 15.7 15.5 8.9 12.1 4.1 6.4 8.5 7.5 9.3 5.7 1.9 1.9 3.2 6.5 0.7 8.8 8.2 10.4 4.8 8.9 18.4 5.2 10.9 6.8 5.6 5.2 11.7 5.3 8.9 4.3 5.5 9.5 3.9 4.9 9.4 5.9 6.9 7.7 5.6 5.9 8.2 9.9 4.3 8.6 5.9 11.7 11.1 10.6 14.8 3.3 11.0 4.2 6.9 12.9 4.1 9.7 5.0 12.2 6.8 7.7 9.0 8.0 9.7 6.4 4.8 8.3 11.3 5.1 11.3 14.1 6.6 9.1 10.4 9.2 10.8 9.3 4.5 5.0 5.8 0.0 1.6 1.9 5.4 1.1 5.6 6.5 5.5 5.2 0.7 9.3 5.6 6.5 0.3 3.2 1.9 5.7 4.2 0.7 14.4 17.2 15.2 19.5 11.3 10.9 13.2 13.4 12.7 15.5 CEP350 "CAP350, KIAA0480" ENSG00000135837 "Centrosomal protein 350" Q5VT06 1 179954738-180114880 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028355, HPA028357, HPA030845, CAB079754" Enhanced Enhanced Centrosome Centrosome "CAB079754: , HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: " "unprognostic (9.52e-2)" "unprognostic (1.18e-1)" "unprognostic (2.78e-1)" "unprognostic (4.20e-2)" "unprognostic (3.68e-2)" "unprognostic (7.12e-3)" "unprognostic (5.17e-3)" "unprognostic (2.85e-1)" "unprognostic (3.65e-3)" "unprognostic (3.84e-2)" "unprognostic (4.86e-2)" "unprognostic (3.25e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (4.22e-1)" "unprognostic (8.38e-2)" "unprognostic (1.46e-2)" "unprognostic (1.13e-1)" 17.2 11.3 13.8 18.9 18.0 26.5 14.0 23.1 14.8 15.3 16.9 13.1 10.5 11.1 13.9 11.9 13.4 11.9 10.8 12.8 13.1 9.4 11.4 12.6 12.4 16.9 17.7 12.3 18.0 13.7 27.2 25.5 14.4 16.2 11.6 13.9 9.0 13.5 12.1 44.2 15.1 22.1 11.5 14.6 17.8 13.4 28.8 18.5 29.8 13.9 11.6 16.5 17.0 20.1 7.2 5.9 8.1 3.7 3.2 6.1 1.3 12.7 9.3 12.0 4.2 10.2 9.5 11.2 8.7 11.7 7.5 8.3 10.3 7.7 14.2 9.5 7.8 15.8 9.0 5.0 9.9 13.7 6.2 10.1 11.7 6.4 11.2 19.9 9.5 9.4 7.9 9.8 12.9 9.2 19.5 10.8 8.1 9.4 11.6 5.6 11.2 2.3 10.1 13.2 10.9 5.3 26.7 8.4 9.0 14.5 9.8 16.6 10.6 17.9 9.3 10.7 7.5 9.4 9.2 18.9 23.8 27.8 5.0 8.6 15.9 2.3 3.7 8.1 5.4 3.4 6.1 4.1 3.9 3.4 3.0 7.2 4.2 3.5 7.3 3.2 3.0 5.9 5.7 1.3 13.8 18.0 23.1 14.8 13.1 9.4 17.7 12.3 16.2 18.5 CEP72 "FLJ10565, KIAA1519" ENSG00000112877 "Centrosomal protein 72" Q9P209 5 612272-667168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.7;HeLa: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.2;NK-cells: 7.7;T-cells: 3.2" "Region enriched" "Detected in single" 8 "cerebellum: 15.8" "Not detected" "Not detected" "HPA058235, HPA074879" Approved Supported Centrosome Centrosome "HPA058235: , HPA074879: " "unprognostic (2.06e-1)" "unprognostic (3.15e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (8.50e-2)" "unprognostic (9.74e-2)" "unprognostic (2.94e-3)" "unprognostic (3.20e-1)" "unprognostic (1.58e-2)" "unprognostic (1.29e-1)" "unprognostic (3.38e-2)" "unprognostic (4.38e-3)" "unprognostic (1.81e-3)" "unprognostic (3.60e-2)" "unprognostic (2.93e-1)" "unprognostic (4.68e-2)" "unprognostic (1.24e-2)" 2.5 2.3 4.7 6.5 6.5 7.1 4.0 7.3 5.9 5.4 3.0 6.6 2.0 3.8 4.8 3.1 4.6 4.5 9.1 2.2 4.5 2.7 2.8 4.2 4.8 6.4 3.8 3.5 7.6 6.2 3.7 4.5 4.0 3.3 3.5 2.5 4.8 4.6 3.2 2.6 6.0 3.4 4.9 3.3 4.0 4.9 18.8 4.3 9.4 4.9 2.6 7.9 2.9 3.6 3.2 0.7 0.6 1.0 7.7 3.2 1.4 4.3 7.1 6.4 9.0 0.6 0.6 11.6 1.9 0.8 4.3 3.8 6.4 6.7 5.1 5.0 0.8 4.2 4.5 3.2 1.7 26.7 7.1 5.7 21.5 2.5 0.8 6.5 3.8 0.7 1.4 3.7 2.5 1.6 5.7 6.1 2.1 3.3 9.7 5.7 4.2 6.7 7.4 3.7 7.1 1.4 3.4 4.9 3.8 13.8 4.6 1.2 4.5 5.1 0.5 4.1 6.1 3.9 2.6 3.9 3.7 5.1 2.6 9.2 4.3 0.0 0.6 0.6 2.4 0.2 3.2 2.6 2.1 2.2 0.2 3.2 3.0 3.0 0.0 7.7 1.0 0.7 2.6 1.4 4.7 6.5 7.3 5.9 4.5 2.7 3.8 3.5 3.3 4.3 CETN3 CEN3 ENSG00000153140 "Centrin 3" O15182 5 90392261-90409786 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035608, HPA063704" Enhanced Supported Centrosome Centrosome "HPA035608: AB_10601098, HPA063704: " "unprognostic (2.08e-1)" "unprognostic (7.31e-2)" "unprognostic (2.41e-1)" "unprognostic (1.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "prognostic unfavourable (2.22e-4)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (8.77e-2)" "unprognostic (5.03e-1)" "unprognostic (5.64e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.53e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" 8.6 11.6 13.7 8.0 16.3 3.6 12.4 11.5 17.9 11.5 8.9 8.7 8.9 5.2 11.0 11.5 11.4 12.0 5.6 14.4 15.6 11.4 10.6 6.9 12.1 9.3 18.2 13.2 17.1 5.8 11.8 34.3 10.0 20.6 10.3 10.7 5.9 7.8 9.7 11.7 8.2 5.6 7.7 37.2 7.6 6.7 63.1 16.5 7.3 7.9 6.1 10.5 7.5 9.6 17.2 19.9 9.4 10.5 11.4 14.9 4.7 16.7 7.4 30.0 6.1 16.9 23.0 18.0 18.3 11.3 17.6 21.9 11.2 20.6 31.7 18.3 8.6 12.0 25.6 24.7 29.2 25.4 11.8 16.1 11.1 14.0 12.1 11.9 10.1 14.4 16.3 12.8 21.4 11.0 20.3 14.2 19.7 11.1 19.6 18.7 10.6 19.1 17.9 21.0 16.1 15.6 6.2 16.4 16.8 17.8 9.2 12.9 17.3 16.1 12.3 10.6 15.2 14.7 24.5 13.2 23.6 28.1 12.4 26.9 10.7 7.8 6.7 9.4 9.3 8.1 9.7 17.2 10.3 9.9 7.4 14.6 14.9 11.9 0.8 11.4 10.5 19.9 8.0 4.7 13.7 16.3 11.5 17.9 15.6 11.4 18.2 13.2 20.6 16.5 CLEC11A "CLECSF3, LSLCL, P47, SCGF" ENSG00000105472 "C-type lectin domain containing 11A" Q9Y240 19 50723329-50725718 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.1" "Group enriched" "Detected in many" 4 "HEL: 44.4;HMC-1: 82.3;NB-4: 109.3;THP-1: 88.3;U-937: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 17.2" "Group enriched" "Detected in many" 4 "dendritic cells: 12.0;monocytes: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042690 Approved Approved Centrosome "Secreted in other tissues" 45000 Centrosome "HPA042690: AB_10795511" "unprognostic (9.33e-2)" "unprognostic (6.66e-2)" "unprognostic (2.40e-2)" "prognostic favourable (6.91e-4)" "unprognostic (2.33e-1)" "unprognostic (8.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.29e-2)" "unprognostic (5.26e-2)" "unprognostic (4.99e-2)" "unprognostic (2.79e-2)" "unprognostic (8.30e-2)" "prognostic unfavourable (1.02e-5)" "unprognostic (6.09e-2)" "unprognostic (8.66e-3)" "unprognostic (4.00e-2)" "unprognostic (1.57e-2)" 5.5 5.4 3.0 5.6 3.1 77.1 4.5 4.5 3.6 33.6 6.5 1.2 6.7 3.9 26.6 27.8 6.7 13.5 10.7 5.6 2.6 3.4 7.4 5.4 7.5 3.5 2.9 1.3 16.1 2.6 2.0 7.5 6.9 4.0 18.9 2.1 8.9 2.9 10.2 3.4 5.0 5.2 8.5 3.4 4.9 3.1 4.9 0.8 4.0 3.8 4.5 2.6 8.4 10.1 0.3 12.0 1.2 17.2 3.4 3.2 6.7 0.3 0.4 0.0 0.3 4.3 5.9 10.1 17.3 4.7 2.0 1.9 0.0 0.0 0.0 0.2 8.6 0.2 0.0 0.0 1.3 0.0 2.8 44.4 0.0 0.0 2.7 0.0 82.3 4.3 0.0 0.2 0.2 2.2 0.5 0.2 3.7 0.3 0.3 109.3 0.2 0.5 3.8 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.0 6.7 0.1 88.3 12.4 0.1 5.4 0.0 0.1 0.2 0.2 0.0 6.3 45.8 5.7 1.0 17.2 0.2 0.6 7.2 0.0 0.3 0.2 0.1 12.0 0.3 1.5 3.2 1.2 3.4 3.3 3.2 0.1 6.7 3.0 3.1 4.5 3.6 2.6 3.4 2.9 1.3 4.0 0.8 CPT1C "CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0" "Cell line enhanced" "Detected in many" "AF22: 18.4;AN3-CA: 15.5;SH-SY5Y: 33.2;U-87 MG: 13.9" "Cancer enhanced" "Detected in many" "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome Centrosome "HPA014529: AB_1847206, HPA063621: " "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favourable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 3.4 9.3 11.2 3.1 18.9 0.8 1.1 16.3 34.0 4.1 1.9 8.9 0.2 2.7 6.4 5.3 1.8 4.1 7.6 2.8 11.9 12.8 1.6 1.6 2.5 2.6 8.0 13.4 3.8 1.2 0.7 15.6 1.9 11.4 2.8 1.7 7.4 1.5 4.8 1.7 1.5 2.4 7.8 6.6 4.2 1.4 4.1 6.3 0.0 1.7 0.2 1.7 4.4 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 18.4 15.5 6.7 5.2 0.0 5.8 11.7 7.5 10.6 0.3 0.0 0.3 0.0 5.8 1.3 0.0 0.0 4.0 0.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.1 0.0 6.1 0.0 10.4 0.0 0.0 0.4 0.3 0.1 0.0 0.8 3.8 0.0 0.0 0.0 0.4 0.0 12.9 33.2 0.0 0.0 0.0 0.0 0.0 8.4 0.3 0.1 3.5 2.9 0.1 1.3 0.1 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.2 18.9 16.3 23.4 11.9 12.8 8.0 13.4 11.4 6.3 DAPK1 "DAPK, ROCO3" ENSG00000196730 "Death associated protein kinase 1" P53355 9 87497228-87708633 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Apoptosis, Translation regulation" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 94.7" "Cell line enhanced" "Detected in many" "HMC-1: 38.7;HUVEC TERT2: 21.9;RPTEC TERT1: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 55 "dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB037302, HPA040472, HPA048436" Approved Approved Centrosome Centrosome "CAB037302: AB_1078622, HPA040472: , HPA048436: " "unprognostic (2.55e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (2.48e-5)" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.75e-1)" "unprognostic (1.88e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-2)" "unprognostic (2.77e-3)" "unprognostic (8.31e-3)" "unprognostic (8.76e-2)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (1.09e-3)" 14.6 4.9 10.4 8.8 25.5 3.8 4.1 2.9 17.6 8.1 16.6 6.5 8.1 7.8 8.7 16.1 4.5 12.2 21.6 4.1 12.4 8.1 14.7 21.3 28.6 8.5 4.6 10.4 32.7 21.2 4.8 16.6 94.7 6.6 5.1 7.5 5.9 9.3 7.3 1.5 3.7 11.0 8.1 4.8 16.4 15.0 6.3 7.3 34.5 7.2 1.5 5.2 13.2 10.5 0.1 5.3 6.9 11.9 0.1 0.1 2.1 0.0 18.2 8.8 6.1 0.2 0.1 14.0 1.2 1.7 7.2 8.1 2.6 0.1 0.1 1.8 0.3 17.0 5.4 0.4 3.1 0.1 4.4 8.8 2.5 8.9 7.8 0.0 38.7 0.5 2.9 1.3 0.5 21.9 6.6 3.7 6.0 0.5 2.6 0.0 9.9 0.0 0.7 7.8 0.0 20.0 18.2 4.0 4.5 0.0 1.8 7.7 0.0 5.8 0.1 0.0 0.1 0.0 0.0 14.6 3.0 0.0 0.1 2.4 1.2 1.3 5.3 6.9 0.0 11.9 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 1.6 0.1 11.7 5.3 0.0 2.1 10.4 25.5 2.9 17.6 12.4 8.1 4.6 10.4 6.6 7.3 DCTN2 "DCTN-50, RBP50" ENSG00000175203 "Dynactin subunit 2" Q13561 12 57530102-57547331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039715, HPA040040" Enhanced Supported Centrosome 3200000 Centrosome "HPA039715: AB_10795154, HPA040040: AB_10794870" "unprognostic (1.70e-2)" "unprognostic (1.82e-1)" "unprognostic (1.54e-1)" "unprognostic (6.88e-2)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (1.38e-7)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" "unprognostic (1.71e-1)" "unprognostic (4.26e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-2)" "unprognostic (9.50e-3)" "unprognostic (2.09e-1)" "unprognostic (1.52e-3)" "unprognostic (3.41e-3)" 24.3 32.6 40.9 18.5 44.3 19.6 25.8 93.4 72.9 28.7 31.5 26.8 23.1 21.4 29.7 34.0 38.5 28.7 21.9 37.4 38.3 48.6 24.8 19.6 21.1 20.7 49.7 44.8 31.0 34.7 31.4 24.6 23.1 41.8 24.7 33.9 15.2 32.7 31.5 40.0 29.7 22.9 42.2 40.2 17.3 28.7 28.7 25.9 18.1 24.8 28.7 29.4 22.5 27.1 24.3 34.7 31.0 36.2 24.9 32.9 38.2 24.3 29.2 32.5 23.9 51.8 54.4 18.8 27.7 48.1 52.4 39.9 21.1 21.4 25.5 32.6 43.7 18.7 26.8 33.2 41.4 29.3 30.2 22.8 18.4 23.7 36.1 15.5 16.9 48.3 55.8 32.6 56.3 52.7 34.7 36.8 49.3 28.4 26.1 19.7 15.8 32.6 19.1 26.9 22.5 40.5 28.6 49.7 33.6 26.7 22.1 24.1 37.1 14.2 42.5 31.8 24.8 19.3 17.9 24.3 23.9 25.5 29.6 18.9 31.1 25.1 31.7 31.0 28.2 36.2 29.9 24.3 28.9 30.5 34.7 22.1 21.6 26.5 18.9 24.9 35.8 26.2 32.9 38.2 40.9 44.3 93.4 72.9 38.3 48.6 49.7 44.8 41.8 25.9 DNAH14 "C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277" ENSG00000185842 "Dynein axonemal heavy chain 14" Q0VDD8 1 224896262-225399292 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 32.4;testis: 29.9" "Cell line enhanced" "Detected in many" "K-562: 25.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 3.5" "Low lineage specificity" "Detected in single" "HPA027718, HPA028545, HPA031379" Uncertain Supported Centrosome Centrosome "HPA027718: AB_10601210, HPA028545: , HPA031379: " "unprognostic (1.16e-1)" "unprognostic (1.77e-2)" "unprognostic (2.95e-1)" "unprognostic (1.86e-2)" "unprognostic (5.92e-2)" "unprognostic (1.09e-3)" "unprognostic (9.94e-4)" "unprognostic (4.23e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.51e-1)" "unprognostic (2.33e-9)" "unprognostic (6.76e-2)" "unprognostic (7.39e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" 1.6 5.2 6.3 2.7 2.5 2.5 5.2 0.9 3.4 3.1 2.9 0.2 3.8 1.7 3.3 6.5 2.0 2.6 5.3 3.7 7.0 5.5 4.2 6.8 5.4 0.6 2.9 4.6 5.5 11.2 3.4 32.4 2.6 7.2 4.3 3.7 3.6 3.4 7.8 0.6 1.0 1.1 4.6 8.5 1.0 3.8 29.9 0.8 3.2 7.1 0.9 0.4 2.5 1.9 0.6 0.2 0.4 0.2 3.5 0.9 0.0 10.2 5.3 4.9 5.3 1.9 4.0 11.7 2.1 2.0 4.0 3.5 8.3 11.4 0.0 5.4 2.1 0.1 7.5 2.0 6.7 0.0 12.5 4.9 3.6 1.8 2.4 10.2 1.7 3.9 4.6 5.4 3.8 1.3 25.2 0.0 6.7 2.7 1.8 10.6 13.7 6.5 0.0 18.5 9.4 3.6 4.8 8.2 9.3 8.3 6.3 16.7 11.5 8.9 0.2 0.0 7.9 0.2 0.0 11.5 7.1 0.1 0.0 0.0 7.4 0.0 0.1 0.3 0.1 0.2 0.0 0.6 0.3 0.7 0.2 0.3 0.4 0.5 0.4 3.5 0.1 0.0 0.9 0.0 6.3 2.5 0.9 3.4 7.0 5.5 2.9 4.6 7.2 0.8 FBF1 "ALB, FBF-1, FLJ00103, KIAA1863" ENSG00000188878 "Fas binding factor 1" Q8TES7 17 75909574-75941140 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023677 Supported Centrosome Centrosome "HPA023677: AB_1848440" "unprognostic (7.40e-3)" "unprognostic (9.90e-3)" "unprognostic (6.62e-2)" "unprognostic (1.38e-3)" "unprognostic (3.14e-3)" "unprognostic (7.88e-4)" "unprognostic (5.76e-4)" "unprognostic (6.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.24e-3)" "unprognostic (6.31e-5)" "unprognostic (6.76e-2)" "unprognostic (1.08e-9)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "unprognostic (3.59e-1)" "unprognostic (1.77e-1)" 4.5 5.5 9.0 4.8 14.9 6.5 3.8 6.1 11.8 3.6 3.1 9.1 8.4 4.0 5.8 11.8 6.4 8.3 5.9 2.7 11.1 6.0 3.9 1.9 4.5 5.5 10.0 8.6 4.9 5.3 5.3 9.8 3.2 10.3 6.4 3.2 5.6 6.0 7.0 2.5 18.0 5.1 3.0 9.4 6.6 3.6 40.4 11.1 5.2 14.0 2.1 5.5 3.6 6.1 0.8 1.9 0.5 1.4 1.1 2.2 0.7 9.5 12.7 3.8 7.1 3.6 2.5 10.6 5.5 1.0 3.9 2.8 3.2 5.6 4.7 3.6 2.6 6.1 2.2 3.9 2.9 2.7 4.2 4.2 7.7 2.4 1.8 1.4 6.6 2.5 4.8 6.4 4.3 2.9 7.7 5.4 2.6 10.7 11.8 4.7 3.2 5.5 9.5 6.2 4.1 1.9 1.6 4.4 4.0 7.8 6.0 3.1 16.6 3.4 1.7 8.5 6.7 4.3 5.0 9.4 2.4 1.9 5.3 3.1 8.1 0.5 0.4 0.4 1.9 1.4 0.5 0.8 1.3 2.0 0.1 0.0 1.5 1.8 0.2 1.1 0.8 1.9 2.2 0.7 9.0 14.9 6.1 11.8 11.1 6.0 10.0 8.6 10.3 11.1 FBXO9 "FBX9, NY-REN-57" ENSG00000112146 "F-box protein 9" Q9UK97 6 53051991-53100873 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064246 Approved Centrosome Centrosome "HPA064246: " "unprognostic (6.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.71e-1)" "unprognostic (9.38e-2)" "unprognostic (3.38e-2)" "unprognostic (3.06e-3)" "unprognostic (6.73e-2)" "unprognostic (1.40e-3)" "unprognostic (2.89e-3)" "prognostic favourable (1.51e-4)" "prognostic favourable (1.82e-4)" "unprognostic (2.50e-1)" "unprognostic (3.41e-1)" "unprognostic (2.29e-1)" "unprognostic (8.73e-2)" "unprognostic (1.56e-2)" "unprognostic (6.64e-3)" 22.6 77.8 19.0 25.2 22.3 47.2 22.8 33.5 42.6 19.4 22.3 15.2 37.2 17.4 21.3 26.6 25.1 20.6 22.6 28.7 20.0 23.8 27.3 38.0 40.5 28.9 22.7 30.5 20.6 32.9 32.7 22.5 28.9 30.4 21.3 18.0 21.8 35.3 43.7 32.0 20.9 19.9 26.9 13.8 22.2 27.0 18.2 17.1 13.8 24.8 29.9 18.3 20.7 18.6 16.0 15.6 14.6 24.2 14.8 14.6 8.4 27.6 11.3 10.6 31.6 21.9 17.8 24.6 26.8 27.3 24.8 24.8 22.1 12.0 14.2 18.4 26.4 17.0 23.1 21.5 31.9 17.5 23.0 34.0 20.9 31.2 18.3 32.2 21.5 23.0 23.7 17.1 17.6 21.0 33.6 22.2 26.0 18.2 13.9 21.1 9.3 16.5 16.2 28.7 17.2 27.2 20.8 38.3 14.6 26.9 19.7 35.4 30.4 31.5 16.9 35.7 24.5 38.8 30.5 23.5 29.6 22.0 17.1 22.3 19.5 14.6 24.2 13.4 12.8 12.6 14.4 14.4 13.1 12.6 15.6 16.0 14.6 11.1 14.4 14.8 12.2 12.3 13.5 8.4 19.0 22.3 33.5 42.6 20.0 23.8 22.7 30.5 30.4 17.1 FGF11 "FHF3, FLJ16061, MGC102953, MGC45269" ENSG00000161958 "Fibroblast growth factor 11" Q92914 17 7438273-7444937 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.5" "Cell line enhanced" "Detected in many" "A-431: 9.3;HaCaT: 16.9;LHCN-M2: 11.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066605, HPA075188" Enhanced Approved Centrosome Centrosome "HPA066605: , HPA075188: " "unprognostic (7.35e-2)" "unprognostic (1.14e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-4)" "unprognostic (9.15e-2)" "unprognostic (3.28e-2)" "unprognostic (7.31e-2)" "unprognostic (3.11e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.69e-2)" "unprognostic (2.89e-3)" "unprognostic (2.00e-6)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.90e-3)" "unprognostic (4.97e-3)" 3.3 23.5 10.5 3.0 13.8 2.1 2.9 4.5 11.6 6.4 1.6 4.6 0.1 1.8 3.1 1.9 13.0 1.7 3.2 11.6 11.7 4.6 3.4 1.1 1.3 6.2 8.1 5.2 1.6 1.3 1.5 1.0 2.0 10.6 1.4 1.4 6.8 3.7 1.7 8.8 19.7 1.3 2.9 4.1 2.4 1.6 2.8 9.9 2.5 7.2 7.1 9.0 2.9 8.7 0.0 0.0 1.6 0.6 0.0 0.3 0.0 9.3 0.6 5.2 0.0 3.0 0.1 2.6 0.2 3.2 0.3 0.6 0.2 1.0 2.8 0.7 0.1 16.9 1.9 5.3 1.2 5.8 4.1 5.1 0.5 1.3 0.5 0.2 5.7 0.6 1.5 0.4 0.2 0.2 2.0 0.2 11.2 2.1 1.6 2.2 1.9 0.2 4.4 4.7 1.1 0.7 0.8 1.1 5.3 0.6 0.6 0.4 0.3 0.4 0.1 0.3 5.6 0.0 0.2 0.4 1.3 0.9 1.3 3.1 0.6 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.0 10.5 13.8 4.5 11.6 11.7 4.6 8.1 5.2 10.6 9.9 FGFR1OP FOP ENSG00000213066 "FGFR1 oncogene partner" O95684 6 166999182-167094789 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071876 Supported Centrosome Centrosome "HPA071876: " "unprognostic (9.14e-2)" "unprognostic (2.24e-1)" "unprognostic (3.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (9.59e-2)" "unprognostic (1.00e-1)" "unprognostic (6.95e-2)" "unprognostic (8.83e-2)" "unprognostic (1.08e-3)" "unprognostic (4.06e-2)" "prognostic unfavourable (7.32e-4)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 6.2 12.2 11.2 12.9 12.5 9.8 10.2 11.9 13.0 10.1 9.5 6.9 11.8 10.8 13.6 14.1 8.8 19.1 7.9 6.4 10.8 9.1 12.2 24.9 6.7 9.4 6.4 11.5 11.8 10.2 8.2 17.2 6.6 9.4 7.4 12.1 8.9 8.1 11.6 5.8 7.9 13.0 7.4 7.4 9.4 7.8 50.3 8.0 14.5 12.5 6.2 11.8 7.0 8.2 6.8 10.0 24.1 4.1 3.5 6.8 3.0 12.0 6.7 17.0 11.6 10.0 7.5 20.7 15.6 10.5 12.8 12.4 24.9 10.3 14.4 8.9 9.5 11.4 14.9 11.0 24.1 9.0 12.9 9.9 12.1 27.0 5.4 17.6 10.5 4.1 8.2 26.2 12.3 8.8 32.3 12.4 16.3 11.1 14.1 25.8 14.5 5.2 16.3 11.6 11.9 13.3 6.5 12.7 12.8 12.7 13.7 5.4 11.2 21.8 5.7 12.8 21.3 15.2 19.5 10.6 14.5 14.6 14.4 16.5 15.6 0.2 4.1 13.5 3.3 3.6 4.9 6.8 3.9 3.1 6.5 5.0 2.3 3.7 24.1 3.5 3.6 10.0 6.8 3.0 11.2 12.5 11.9 13.0 10.8 9.1 6.4 11.5 9.4 8.0 FKBP11 FKBP19 ENSG00000134285 "FK506 binding protein 11" Q9NYL4 12 48921518-48926474 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 175.6;salivary gland: 62.0" "Cell line enhanced" "Detected in many" "HHSteC: 46.2;Karpas-707: 42.0;RPMI-8226: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 37.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041709 Enhanced Approved Centrosome Centrosome "HPA041709: AB_10794487" "unprognostic (7.45e-3)" "unprognostic (8.62e-2)" "unprognostic (2.40e-1)" "prognostic favourable (7.09e-4)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (3.46e-2)" "unprognostic (1.75e-1)" "unprognostic (7.64e-2)" "unprognostic (3.49e-3)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.15e-1)" "unprognostic (4.51e-1)" "unprognostic (2.79e-1)" "unprognostic (1.54e-1)" 5.6 4.6 1.1 8.2 1.4 3.7 3.7 0.9 2.2 7.5 6.9 0.9 21.6 9.2 4.4 12.9 4.4 4.8 8.1 3.4 1.3 2.4 4.8 38.4 5.8 16.6 1.0 1.3 3.7 175.6 0.2 12.3 3.3 1.6 4.8 6.3 1.9 62.0 20.9 1.4 1.7 7.6 2.9 1.0 18.7 10.0 1.9 0.9 2.2 4.7 4.9 14.5 8.2 4.3 11.1 8.3 1.1 0.3 5.1 37.6 7.3 2.1 2.8 0.5 0.7 12.6 19.1 1.0 16.6 23.9 18.4 21.8 10.7 12.0 32.4 0.5 27.2 8.9 5.8 7.3 9.6 6.8 1.2 1.2 3.0 0.1 46.2 0.6 0.9 21.3 14.2 14.1 26.3 10.4 0.4 42.0 6.7 6.0 4.8 1.1 1.4 5.3 13.3 0.8 42.0 2.3 0.4 6.9 2.0 5.5 8.3 3.7 0.5 1.0 8.3 3.6 0.7 0.3 0.3 24.6 20.3 16.4 2.2 0.7 5.9 0.9 0.2 0.6 22.5 0.3 37.6 11.1 15.6 17.7 0.3 4.8 9.4 14.4 1.1 5.1 0.1 8.3 6.4 7.3 1.1 1.4 0.9 2.2 1.3 2.4 1.0 1.3 1.6 0.9 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986720-65062652 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 75.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome Centrosome "HPA062743: " "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavourable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 7.4 9.0 6.3 4.9 21.9 2.3 7.8 11.4 13.7 8.0 6.3 24.3 6.2 5.6 6.4 6.6 13.5 9.0 5.1 12.0 8.1 7.9 8.0 5.6 7.0 5.1 34.0 7.2 7.4 5.9 13.6 7.9 8.2 25.4 8.9 7.9 4.4 8.0 9.6 14.3 10.3 5.1 11.6 75.0 4.6 5.7 9.0 22.2 4.7 5.6 5.8 7.3 7.4 7.8 2.4 6.4 12.3 10.3 2.8 8.8 5.3 18.3 13.4 10.4 5.9 6.7 5.9 7.6 10.6 7.8 12.0 12.4 7.1 7.6 3.1 6.1 11.2 12.2 25.0 8.3 9.9 4.4 7.0 12.4 3.6 10.3 4.4 4.2 17.2 5.0 7.2 5.2 2.8 10.0 6.7 4.5 7.0 12.1 6.4 7.0 4.5 13.6 6.3 9.7 3.9 8.3 6.8 6.6 6.6 6.6 13.0 14.4 12.0 7.4 7.9 8.7 18.0 3.9 6.8 2.3 2.6 3.2 10.1 5.5 20.1 12.3 10.3 9.2 3.6 8.6 8.8 2.4 5.5 4.3 6.4 1.9 4.5 3.3 2.7 2.8 4.3 4.9 5.1 5.3 6.3 21.9 11.4 13.7 8.1 7.9 34.0 7.2 25.4 22.2 FOPNL "C16orf63, DKFZp686N1651, FLJ31153, FOR20, PHSECRG2" ENSG00000133393 "FGFR1OP N-terminal like" Q96NB1 16 15865720-15888625 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040599 Supported Supported Centrosome Centrosome "HPA040599: AB_10794036" "unprognostic (1.10e-1)" "unprognostic (6.29e-2)" "unprognostic (1.16e-3)" "unprognostic (7.16e-2)" "unprognostic (2.45e-1)" "unprognostic (3.77e-2)" "unprognostic (2.23e-2)" "unprognostic (6.01e-2)" "unprognostic (1.72e-1)" "unprognostic (4.92e-1)" "unprognostic (4.35e-2)" "unprognostic (4.78e-1)" "unprognostic (6.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (5.45e-3)" 12.0 21.6 15.6 13.4 17.3 13.2 21.4 13.1 19.5 14.2 16.0 14.5 9.5 13.7 11.7 9.3 21.3 12.8 15.4 15.4 14.0 14.7 19.4 18.3 11.3 23.8 16.5 11.3 16.8 14.3 15.5 16.4 14.7 17.9 14.3 15.3 14.5 11.4 13.2 32.7 18.3 12.5 13.1 12.9 13.9 11.4 21.7 13.0 25.7 36.0 22.1 16.4 20.5 13.0 13.9 14.9 23.7 12.9 16.0 15.3 13.6 15.2 16.4 5.9 0.9 13.5 16.8 0.7 8.5 9.9 8.8 10.4 8.8 1.5 11.1 11.1 2.1 12.4 14.6 1.1 18.6 11.7 10.8 1.6 3.9 3.3 11.4 3.1 12.3 1.5 20.0 1.9 13.6 14.8 29.8 1.4 2.3 11.6 9.6 11.8 14.6 0.9 2.1 13.9 1.1 1.1 4.7 5.3 0.4 0.8 11.1 18.3 1.3 1.3 5.0 1.2 1.1 17.3 29.9 4.0 12.8 18.4 16.0 25.9 12.9 23.7 12.9 6.0 11.7 12.7 15.2 13.9 14.4 13.8 13.4 13.7 15.3 14.1 3.7 16.0 10.5 14.9 13.6 13.6 15.6 17.3 13.1 19.5 14.0 14.7 16.5 11.3 17.9 13.0 GABBR1 "GPRC3A, hGB1a" ENSG00000204681 "Gamma-aminobutyric acid type B receptor subunit 1" Q9UBS5 6 29555629-29633976 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.8" "Cell line enhanced" "Detected in many" "AN3-CA: 8.0;HEL: 7.7;U-2 OS: 8.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050483, HPA058459" Uncertain Approved Centrosome "Intracellular and membrane" Centrosome "HPA050483: , HPA058459: " "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (3.22e-3)" "unprognostic (2.93e-3)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (7.95e-4)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "prognostic favourable (2.54e-5)" "unprognostic (1.23e-3)" "prognostic unfavourable (3.77e-10)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.87e-2)" "unprognostic (2.55e-2)" 14.0 7.4 33.6 7.0 47.2 8.2 4.2 29.1 53.8 6.9 5.6 17.3 3.0 2.3 18.1 1.9 2.9 7.9 4.1 4.6 24.8 21.4 2.9 2.0 6.9 6.6 15.6 33.7 7.8 5.1 1.8 5.8 5.0 22.3 12.8 3.2 4.4 13.0 13.3 8.5 18.3 6.1 5.5 14.9 24.2 6.1 4.3 15.4 0.0 3.9 0.1 5.2 4.0 5.9 1.8 1.7 0.0 0.5 0.0 0.4 0.3 2.9 0.0 1.9 8.0 0.9 2.1 2.1 2.0 0.8 1.8 0.5 2.3 0.1 1.4 2.0 0.0 2.4 0.9 0.0 0.0 7.2 3.4 7.7 3.4 0.0 1.2 0.3 4.0 0.0 0.0 1.6 0.0 1.0 6.6 0.0 0.3 1.9 0.7 0.1 0.6 1.1 3.5 0.7 0.1 0.3 0.0 0.5 1.3 0.5 0.0 3.3 1.5 1.1 4.5 3.2 8.3 0.3 3.7 7.0 0.7 0.0 1.8 3.5 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 33.6 47.2 29.1 53.8 24.8 21.4 15.6 33.7 22.3 15.4 GRAP ENSG00000154016 "GRB2-related adaptor protein" Q13588 17 19020673-19047637 "Plasma proteins, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.3;lymphoid tissue: 20.9" "Cell line enhanced" "Detected in some" "Daudi: 31.7;HUVEC TERT2: 13.1;REH: 16.6;TIME: 25.7;U-698: 22.3" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 28.2;T-cells: 37.3" "HPA046595, HPA066654" Uncertain Approved Centrosome Centrosome "HPA046595: AB_10966385, HPA066654: " "unprognostic (3.02e-1)" "unprognostic (6.85e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (3.43e-2)" "unprognostic (3.86e-6)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (4.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (5.11e-2)" "unprognostic (2.67e-5)" "unprognostic (2.25e-1)" "unprognostic (1.57e-2)" "unprognostic (2.16e-1)" "unprognostic (5.77e-3)" 2.8 1.4 0.7 5.7 0.9 2.4 2.8 0.1 0.4 1.4 0.6 0.3 1.4 0.0 0.5 1.9 2.1 0.6 0.8 0.6 2.2 2.7 3.5 15.8 1.0 0.6 0.1 0.0 0.7 2.5 1.0 0.4 0.4 1.6 0.3 0.8 7.7 1.1 1.0 20.9 0.5 2.5 2.7 14.2 1.7 0.8 28.2 2.7 5.6 2.5 4.9 37.3 13.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 0.0 0.0 6.5 0.5 0.3 0.0 16.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 25.7 0.0 0.0 3.1 0.0 0.0 0.0 22.3 0.0 0.0 0.1 5.6 2.5 0.3 5.9 1.3 5.9 28.2 18.5 7.7 2.7 22.8 37.3 17.9 0.7 4.9 0.1 2.0 15.4 13.0 GRAPL ENSG00000189152 "GRB2 related adaptor protein like" Q8TC17 17 19127469-19159176 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6" "Group enriched" "Detected in some" 7 "Daudi: 21.7;HUVEC TERT2: 9.0;TIME: 24.0;U-698: 20.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 10.8" "Lineage enriched" "Detected in many" 5 "B-cells: 10.8" "HPA051796, HPA066654" Uncertain Approved Centrosome Centrosome "HPA051796: , HPA066654: " "unprognostic (2.85e-1)" "unprognostic (3.37e-1)" "unprognostic (5.09e-4)" "unprognostic (4.49e-2)" "unprognostic (6.45e-2)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.76e-1)" "unprognostic (5.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.28e-2)" "unprognostic (8.29e-2)" "unprognostic (2.14e-1)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" 4.6 1.6 0.7 9.5 1.7 1.0 1.7 0.4 2.0 1.5 1.3 0.1 2.9 0.7 3.6 1.9 2.5 1.6 2.2 3.4 1.7 0.8 2.8 1.8 4.6 15.6 1.1 1.2 1.1 0.4 0.0 1.0 1.7 1.0 1.4 1.3 1.0 1.4 1.3 2.3 0.7 9.7 1.9 0.9 20.6 0.8 1.1 0.5 7.7 2.7 1.7 17.0 1.7 2.3 10.8 0.1 0.0 0.0 0.0 2.2 0.7 0.0 1.2 1.5 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.3 21.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.0 2.7 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 24.0 0.0 0.2 1.1 0.0 0.0 0.0 20.1 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 10.8 1.4 0.3 0.1 4.1 2.2 0.7 0.0 0.0 0.0 0.0 0.9 0.7 0.7 1.7 0.4 2.0 1.7 0.8 1.1 1.2 1.0 0.5 HPS4 "BLOC3S2, KIAA1667, LE" ENSG00000100099 "HPS4, biogenesis of lysosomal organelles complex 3 subunit 2" Q9NQG7 22 26443423-26483837 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033106, HPA050189" Approved Approved Centrosome Centrosome "CAB033106: AB_2264349, HPA050189: " "unprognostic (1.55e-2)" "unprognostic (1.02e-1)" "unprognostic (9.82e-2)" "unprognostic (5.30e-3)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (1.83e-3)" "unprognostic (1.59e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (2.23e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (6.46e-2)" 7.9 9.6 10.7 7.4 16.3 11.3 8.4 43.1 16.4 11.9 8.0 14.1 9.5 6.6 11.2 10.1 10.5 11.8 7.4 5.0 9.4 11.8 10.7 7.9 8.0 10.8 10.7 11.9 15.8 15.5 14.5 18.7 6.7 12.0 8.9 6.9 15.7 10.8 10.2 5.0 17.1 7.4 8.9 10.5 9.0 8.8 18.2 8.3 18.0 12.3 4.0 12.7 8.0 8.8 7.8 7.3 12.6 4.0 9.2 6.9 5.7 7.4 3.5 7.4 7.5 5.6 6.6 3.9 4.5 8.8 10.2 9.2 3.7 3.7 7.1 3.6 5.5 6.2 7.0 9.8 9.3 5.2 7.3 7.2 3.1 6.0 10.0 8.4 8.1 6.5 8.1 9.3 16.6 6.6 7.8 9.0 7.4 3.1 14.0 2.9 4.4 3.8 39.4 8.7 9.2 4.7 4.7 8.4 6.2 4.3 5.1 22.0 5.4 6.4 4.1 12.0 22.5 5.9 5.6 13.5 10.4 23.3 7.8 5.4 7.7 12.6 4.0 4.0 6.6 3.0 6.2 7.8 5.4 5.6 5.6 6.7 6.4 6.9 1.4 9.2 2.6 7.3 3.6 5.7 10.7 16.3 43.1 16.4 9.4 11.8 10.7 11.9 12.0 8.3 INPP4B ENSG00000109452 "Inositol polyphosphate-4-phosphatase type II B" O15327 4 142023160-142847432 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.5;SK-MEL-30: 22.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 19.2" "Group enriched" "Detected in many" 6 "NK-cells: 9.1;T-cells: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037681, HPA037682" Approved Approved Centrosome Centrosome "HPA037681: AB_10670389, HPA037682: AB_10671377" "unprognostic (9.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.25e-2)" "unprognostic (1.77e-1)" "unprognostic (8.24e-2)" "unprognostic (3.03e-3)" "unprognostic (5.76e-3)" "unprognostic (1.95e-2)" "unprognostic (3.16e-1)" "prognostic unfavourable (1.03e-4)" "unprognostic (8.58e-2)" "unprognostic (1.26e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (1.39e-2)" 15.4 4.7 8.4 8.5 12.5 2.2 21.2 5.1 10.3 28.1 7.1 1.8 5.6 5.0 19.7 18.4 9.1 9.2 8.7 18.4 5.9 6.1 6.1 2.0 9.9 10.8 5.5 8.9 15.4 4.0 2.3 3.8 6.2 4.6 8.3 5.8 1.7 4.9 6.8 10.8 4.7 7.3 10.2 3.1 7.0 7.0 19.6 2.4 8.2 6.5 4.9 7.4 15.8 14.6 0.0 0.0 2.2 0.1 9.1 19.2 3.7 9.1 3.8 2.5 1.2 1.9 1.2 0.5 11.1 13.0 2.8 5.4 1.0 51.5 0.2 3.1 9.9 14.0 0.0 12.9 6.7 0.0 0.3 2.2 1.4 0.0 0.6 0.4 1.7 2.1 1.8 2.0 6.8 1.6 0.0 0.5 6.1 16.3 0.3 0.0 0.1 2.8 0.1 8.6 0.4 3.9 17.0 0.2 0.2 1.2 3.9 22.9 11.8 1.6 1.0 6.6 8.1 9.7 0.1 0.1 0.0 0.0 1.5 10.0 17.0 2.2 0.1 0.0 3.3 0.0 6.5 0.0 19.2 8.5 0.0 0.0 13.2 5.7 0.2 9.1 0.0 0.0 9.8 3.7 8.4 12.5 5.1 10.3 5.9 6.1 5.5 8.9 4.6 2.4 ITPRIPL2 "FLJ22994, LOC162073, MGC126798, MGC126800" ENSG00000205730 "ITPRIP like 2" Q3MIP1 16 19113932-19121629 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042011 Approved Centrosome Centrosome "HPA042011: " "unprognostic (1.07e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (9.64e-2)" "unprognostic (1.97e-1)" "unprognostic (2.20e-1)" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (5.60e-2)" "unprognostic (1.90e-2)" "unprognostic (5.26e-3)" "unprognostic (4.24e-2)" "unprognostic (1.53e-1)" "unprognostic (7.23e-2)" "unprognostic (6.37e-2)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" 32.6 10.7 6.2 8.3 6.0 0.9 25.8 1.2 4.1 16.0 11.4 4.3 8.2 6.1 12.7 10.6 16.4 10.2 12.7 9.9 3.8 2.8 6.4 9.5 16.7 5.1 5.6 2.1 11.6 15.0 8.5 4.7 26.5 5.7 19.1 5.9 9.5 8.5 8.9 7.3 19.7 9.1 11.3 4.0 7.8 9.9 4.9 5.7 2.0 12.0 12.8 8.0 14.2 25.7 0.5 1.9 1.3 6.6 0.2 0.6 0.6 9.0 5.3 2.1 7.0 18.2 27.8 14.0 14.4 10.2 4.2 3.9 2.2 16.3 0.0 14.9 11.4 10.3 2.9 4.4 5.6 0.0 3.0 0.7 10.7 3.8 11.8 0.0 0.0 18.4 12.3 8.2 9.4 5.5 1.3 0.0 10.0 6.1 0.0 0.2 2.1 7.1 0.0 0.3 0.0 6.4 15.2 0.2 2.7 11.8 1.2 7.0 7.0 1.4 10.9 14.8 6.4 7.5 5.4 0.1 0.0 0.0 8.6 0.3 7.4 1.3 2.8 0.3 0.6 3.4 0.3 0.5 0.3 0.5 1.9 0.3 0.2 0.5 1.0 0.2 6.6 1.2 0.1 0.6 6.2 6.0 1.2 4.1 3.8 2.8 5.6 2.1 5.7 5.7 KIF6 "C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317" ENSG00000164627 "Kinesin family member 6" Q6ZMV9 6 39329990-39725405 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6" "Cell line enhanced" "Detected in some" "RPMI-8226: 10.4;SCLC-21H: 14.6;SK-MEL-30: 5.9;U-2197: 3.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038811, HPA058624" Enhanced Approved Centrosome Centrosome "HPA038811: AB_10795140, HPA058624: " "unprognostic (4.94e-2)" "unprognostic (3.38e-2)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (1.55e-1)" "unprognostic (8.25e-4)" "unprognostic (3.12e-3)" "unprognostic (1.00e-1)" "unprognostic (3.06e-1)" "unprognostic (3.48e-2)" "unprognostic (9.12e-4)" "unprognostic (1.08e-1)" "unprognostic (3.07e-2)" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" 1.3 1.4 5.1 0.7 9.1 0.9 1.9 2.2 11.4 1.4 1.0 18.8 0.1 1.7 1.0 2.6 1.3 9.9 1.6 1.3 7.3 7.1 1.4 1.3 2.4 1.2 11.8 3.2 1.8 1.6 1.2 5.6 1.2 8.6 1.1 0.9 1.7 1.0 0.9 1.6 1.2 1.1 0.8 10.6 0.9 0.9 12.6 7.8 0.0 2.0 0.0 0.9 0.7 0.4 1.2 2.7 2.5 0.6 1.3 0.7 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.3 0.7 0.1 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.3 0.0 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.6 10.4 0.3 0.1 14.6 0.2 0.0 0.1 5.9 0.1 0.1 0.2 0.1 0.2 3.4 0.8 0.2 0.0 0.0 0.8 0.1 1.8 1.9 0.6 0.4 0.5 0.3 0.5 0.7 0.5 0.4 0.2 1.2 0.6 0.7 2.5 1.3 0.4 2.7 0.3 0.1 5.1 9.1 2.2 5.4 7.3 7.1 11.8 3.2 8.6 7.8 KIFC1 "HSET, KNSL2" ENSG00000237649 "Kinesin family member C1" Q9BW19 6 33391536-33409924 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 60.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055997, HPA062674" Enhanced Approved Centrosome Centrosome "HPA055997: , HPA062674: " "unprognostic (7.33e-2)" "unprognostic (1.28e-2)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "prognostic unfavourable (7.07e-8)" "unprognostic (6.34e-3)" "unprognostic (9.36e-3)" "unprognostic (8.58e-2)" "prognostic unfavourable (4.21e-4)" "unprognostic (1.83e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.17e-2)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (4.52e-1)" 0.9 0.8 0.0 18.0 0.3 9.6 1.5 0.0 0.5 1.7 5.7 0.1 0.3 3.0 0.9 1.6 10.1 0.5 2.2 0.8 0.0 0.0 0.7 0.7 2.2 6.3 0.1 0.2 1.5 0.3 0.2 0.2 3.6 0.4 0.6 2.5 0.6 1.7 0.1 0.4 3.3 4.2 0.7 0.4 4.7 2.5 9.7 0.2 60.9 0.4 7.4 14.6 0.6 2.8 0.8 0.3 0.0 0.1 0.2 1.4 0.7 10.6 1.8 10.2 10.7 0.2 0.4 6.2 7.7 1.9 6.1 5.2 3.7 4.7 7.0 3.0 1.6 5.8 2.6 3.6 6.7 4.1 5.8 5.7 8.6 5.4 0.0 4.6 6.3 0.0 0.9 5.1 1.5 0.5 1.7 17.4 4.6 2.7 2.7 9.3 4.7 2.2 7.0 5.7 2.4 0.9 2.4 9.3 4.1 2.8 5.9 1.4 6.2 4.8 1.4 3.2 10.0 5.4 11.4 5.7 10.9 6.8 0.0 6.9 5.7 0.0 0.1 0.0 0.4 0.0 0.6 0.8 0.3 1.4 0.3 0.8 0.3 0.3 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.2 0.4 0.2 KLHL21 KIAA0469 ENSG00000162413 "Kelch like family member 21" Q9UJP4 1 6590724-6614607 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 9.7;neutrophil: 31.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051364, HPA059307" Uncertain Supported Centrosome Centrosome "HPA051364: , HPA059307: " "unprognostic (6.13e-3)" "unprognostic (5.26e-2)" "unprognostic (2.30e-2)" "unprognostic (9.09e-2)" "unprognostic (4.04e-2)" "unprognostic (2.39e-2)" "unprognostic (5.77e-3)" "unprognostic (2.28e-1)" "unprognostic (8.52e-2)" "unprognostic (4.85e-2)" "unprognostic (4.02e-1)" "unprognostic (6.33e-3)" "prognostic favourable (1.71e-4)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (9.74e-2)" "unprognostic (4.19e-2)" 18.1 11.3 8.7 7.8 16.1 13.6 20.0 7.3 12.7 11.9 14.6 19.1 12.0 4.6 13.7 6.0 17.3 8.5 14.8 20.5 8.6 7.3 11.7 9.1 8.7 7.5 31.2 5.4 18.0 21.0 8.7 11.2 4.4 14.0 15.7 3.5 17.1 20.4 19.4 58.7 15.1 5.4 22.9 9.9 6.5 10.1 6.6 22.4 4.5 10.1 13.8 7.4 19.4 19.5 2.2 1.8 31.2 3.0 1.4 3.8 2.5 9.8 5.9 3.0 9.7 17.0 10.6 7.8 13.9 11.2 9.2 5.5 17.2 6.4 0.4 12.4 8.5 16.3 6.5 15.3 5.2 21.0 10.6 11.4 10.6 15.4 14.1 6.7 7.0 11.8 5.2 20.9 7.1 3.9 12.5 9.2 7.5 3.4 6.9 5.9 5.5 22.0 10.7 12.5 12.3 5.4 3.0 12.2 3.0 10.9 8.8 24.5 5.7 8.1 13.0 30.1 3.7 27.6 33.2 10.5 13.0 6.9 29.2 12.8 11.2 3.6 3.0 9.7 3.6 1.2 3.3 2.2 3.4 3.6 1.8 1.4 2.9 2.7 31.2 1.4 1.1 1.7 3.8 2.5 8.7 16.1 7.3 12.7 8.6 7.3 31.2 5.4 14.0 22.4 LEPROT "FLJ90360, OB-RGRP, OBRGRP, VPS55" ENSG00000213625 "Leptin receptor overlapping transcript" O15243 1 65420587-65436007 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069444 Approved Centrosome Centrosome "HPA069444: " "unprognostic (3.64e-2)" "unprognostic (2.24e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "unprognostic (6.13e-3)" "unprognostic (1.52e-1)" "unprognostic (2.21e-1)" "unprognostic (4.88e-2)" "unprognostic (6.85e-2)" "unprognostic (6.43e-3)" "unprognostic (2.25e-2)" "unprognostic (4.56e-3)" "unprognostic (2.25e-3)" "unprognostic (8.22e-2)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" 37.3 30.0 13.9 12.6 14.0 17.1 37.8 9.2 13.3 25.4 20.5 18.0 16.1 12.5 42.6 18.4 25.5 20.7 20.8 22.1 11.4 11.0 50.7 31.1 26.3 24.5 16.5 10.1 28.7 30.8 22.5 21.7 44.3 18.9 25.4 16.9 30.4 21.4 20.5 13.6 16.2 23.5 26.2 20.0 24.3 18.1 17.4 11.7 6.5 34.2 14.0 14.7 28.5 19.5 2.2 8.1 15.3 18.0 4.1 4.9 8.4 10.5 4.4 4.6 2.0 41.1 27.8 14.8 16.4 23.0 13.3 13.5 3.8 6.7 2.5 9.5 16.4 6.6 2.5 6.8 17.0 11.3 2.6 12.2 5.7 6.8 11.4 2.3 6.5 38.0 17.3 10.7 8.4 15.2 7.2 6.0 23.9 2.6 0.9 2.8 7.4 4.9 0.5 10.3 3.8 59.8 7.9 4.7 6.3 10.0 8.9 9.5 6.8 4.5 17.7 13.6 10.0 10.3 6.1 7.4 6.6 1.1 10.9 6.2 8.5 15.3 12.7 10.7 4.1 12.7 4.9 2.2 3.9 3.7 8.1 1.5 3.9 3.8 11.8 4.1 18.0 6.7 3.0 8.4 13.9 14.0 9.2 13.3 11.4 11.0 16.5 10.1 18.9 11.7 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell line enhanced" "Detected in some" "AF22: 22.2;HAP1: 4.0;RPMI-8226: 10.2;SCLC-21H: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Approved Centrosome "Secreted to blood" Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.0 4.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.6 0.7 0.0 0.9 10.2 0.4 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 LINC02203 ENSG00000280709 "Long intergenic non-protein coding RNA 2203" 15 21552795-21653276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 11.7" "Cell line enriched" "Detected in single" 21 "U-2 OS: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Approved Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 LMF2 "TMEM112B, TMEM153" ENSG00000100258 "Lipase maturation factor 2" Q9BU23 22 50502949-50507691 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062626 Approved Approved Centrosome Centrosome "HPA062626: " "unprognostic (2.69e-1)" "prognostic favourable (3.47e-4)" "unprognostic (8.67e-2)" "unprognostic (2.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.13e-2)" "unprognostic (1.21e-2)" "unprognostic (2.70e-2)" "unprognostic (5.11e-2)" "unprognostic (2.90e-1)" "unprognostic (2.97e-2)" "unprognostic (3.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.08e-1)" "unprognostic (2.54e-2)" "unprognostic (8.75e-2)" 18.2 13.7 7.7 14.3 10.1 20.9 16.9 14.6 16.6 16.9 20.0 16.1 11.0 18.7 14.7 19.3 17.5 13.0 19.0 11.2 8.1 8.7 18.5 34.7 14.2 15.3 10.7 10.1 18.0 122.0 8.7 20.8 14.2 11.3 15.8 5.3 16.9 27.3 16.4 10.8 17.8 21.3 11.3 7.8 19.0 12.9 12.0 7.8 12.8 20.4 13.9 19.9 13.3 14.1 10.8 25.3 16.1 17.7 12.1 21.0 12.6 17.9 13.5 7.7 14.7 11.2 9.7 18.1 32.2 17.1 20.8 23.3 13.3 9.4 8.0 8.7 16.9 21.6 2.6 10.2 2.9 6.2 28.3 4.4 24.8 14.0 14.1 8.2 17.4 14.2 9.5 14.1 3.5 11.5 5.2 26.9 9.0 12.9 5.8 9.7 4.6 16.9 13.2 12.4 21.6 8.4 9.8 6.9 10.2 21.9 19.1 14.7 10.9 5.8 16.6 29.4 16.7 21.0 1.6 10.4 3.3 4.8 21.3 5.0 23.9 10.3 13.2 16.1 21.0 17.7 15.9 10.8 17.5 19.4 14.0 7.3 10.4 10.9 12.4 12.1 14.5 25.3 15.9 12.6 7.7 10.1 14.6 16.6 8.1 8.7 10.7 10.1 11.3 7.8 LRRCC1 "CLERC, KIAA1764, VFL1" ENSG00000133739 "Leucine rich repeat and coiled-coil centrosomal protein 1" Q9C099 8 85107147-85146076 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.1" "Cell line enhanced" "Detected in many" "HDLM-2: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012893, HPA075880" Uncertain Supported Centrosome Centrosome "HPA012893: AB_1852434, HPA075880: " "unprognostic (1.01e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-3)" "unprognostic (2.37e-2)" "unprognostic (7.67e-2)" "unprognostic (7.76e-2)" "unprognostic (1.47e-2)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.31e-1)" "unprognostic (4.45e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-2)" "unprognostic (2.43e-2)" "unprognostic (2.67e-2)" "unprognostic (7.37e-2)" "unprognostic (1.52e-1)" 5.2 5.6 10.8 9.8 10.7 7.0 7.3 2.3 7.2 7.0 10.8 5.6 5.1 7.3 7.1 7.3 6.1 5.2 4.8 5.3 10.4 9.0 9.7 4.4 6.1 4.9 12.7 6.0 9.4 4.8 6.0 2.7 2.5 8.8 8.9 10.1 3.4 3.6 6.8 2.0 6.5 10.0 11.7 15.0 5.3 6.5 33.1 9.9 11.4 10.1 3.4 3.9 8.0 22.1 1.3 2.9 0.1 1.2 2.5 3.6 0.6 4.3 0.9 8.2 1.9 4.0 3.5 6.5 4.7 2.9 1.0 1.8 2.2 6.3 3.2 0.7 2.8 6.0 9.7 2.7 1.6 25.3 0.8 12.7 2.5 3.2 1.2 4.8 3.4 2.0 0.7 2.8 0.6 1.1 14.3 3.0 5.2 1.6 14.5 3.8 2.8 2.1 10.7 5.2 2.2 2.8 3.3 1.1 2.8 2.2 4.3 1.6 9.8 10.5 1.4 4.0 5.4 4.2 6.1 4.1 4.0 6.4 3.3 12.6 7.7 0.0 0.8 0.0 1.8 1.2 0.9 1.3 1.4 1.9 2.9 1.2 1.6 2.8 0.1 2.5 0.9 1.9 3.6 0.6 10.8 10.7 2.3 7.2 10.4 9.0 12.7 6.0 8.8 9.9 LTB "p33, TNFC, TNFSF3" ENSG00000227507 "Lymphotoxin beta" Q06643 6 31580525-31582522 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;lymphoid tissue: 81.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;Daudi: 19.4;HDLM-2: 10.9;NB-4: 12.6;REH: 11.9;U-698: 14.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048884 Approved Approved Centrosome Centrosome "HPA048884: " "unprognostic (1.43e-2)" "unprognostic (3.89e-2)" "unprognostic (7.29e-2)" "prognostic favourable (2.36e-6)" "unprognostic (2.91e-3)" "prognostic favourable (1.74e-4)" "unprognostic (1.45e-1)" "unprognostic (9.49e-3)" "unprognostic (1.42e-3)" "unprognostic (4.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (3.31e-7)" "unprognostic (8.91e-2)" "unprognostic (4.92e-2)" "unprognostic (6.56e-3)" "unprognostic (1.99e-1)" 1.0 0.2 0.2 35.9 0.2 3.4 0.5 0.1 0.1 0.2 1.5 0.0 0.0 1.3 0.2 0.3 2.7 0.4 0.7 1.9 0.2 0.1 4.2 1.3 4.2 27.8 0.2 0.0 0.5 0.8 0.0 0.2 0.3 0.1 0.7 0.6 0.5 6.1 0.3 0.1 0.6 18.0 0.3 0.3 69.7 2.0 0.2 0.0 81.5 1.1 0.8 41.6 1.6 0.5 44.1 15.6 17.8 3.6 5.2 39.3 10.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 19.4 0.2 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 12.6 0.0 0.0 11.9 0.0 2.7 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 2.5 0.4 17.8 3.7 2.0 26.8 42.5 39.3 17.3 0.6 44.1 33.5 14.2 14.5 5.2 3.6 15.6 22.2 10.7 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.0 MAP7D3 FLJ12649 ENSG00000129680 "MAP7 domain containing 3" Q8IWC1 X 136213220-136256482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA035598, HPA058101" Approved Enhanced Centrosome Centrosome "HPA035598: AB_10671108, HPA058101: " "unprognostic (2.89e-1)" "unprognostic (1.23e-1)" "unprognostic (9.56e-2)" "prognostic unfavourable (9.00e-5)" "unprognostic (8.83e-3)" "unprognostic (3.77e-3)" "unprognostic (4.16e-5)" "unprognostic (5.35e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (9.91e-2)" "prognostic unfavourable (7.91e-4)" "unprognostic (2.04e-1)" "unprognostic (1.01e-2)" "prognostic unfavourable (5.38e-5)" 26.1 4.8 2.9 9.3 3.8 4.5 21.2 0.9 2.2 14.3 9.0 1.7 6.8 2.2 11.4 12.3 10.6 13.7 6.7 17.7 2.7 1.9 9.9 6.5 6.9 6.4 4.1 1.1 23.6 2.8 8.3 14.1 32.6 5.5 9.4 3.5 4.6 3.8 8.6 27.9 5.3 6.2 15.3 6.5 11.8 6.5 16.0 3.1 9.5 9.6 10.2 4.9 13.9 14.6 9.8 6.2 5.9 9.2 8.4 9.3 3.9 15.4 5.5 4.2 7.2 9.5 10.0 5.8 15.0 8.3 12.3 17.0 5.5 7.8 8.0 24.3 13.1 7.5 12.2 8.0 16.9 7.3 12.2 4.8 8.8 0.0 10.5 11.8 5.0 20.3 4.6 12.6 15.7 9.6 4.1 12.7 9.1 9.8 13.9 4.5 5.9 0.1 13.8 11.4 4.0 0.4 2.4 3.0 6.3 8.7 3.3 5.4 0.0 5.4 28.5 13.2 7.6 16.7 19.0 8.6 10.3 9.2 9.0 19.8 6.2 5.9 4.8 1.4 7.5 5.5 9.3 9.8 7.1 8.2 5.8 8.5 7.6 6.0 1.0 8.4 9.2 6.2 5.0 3.9 2.9 3.8 0.9 2.2 2.7 1.9 4.1 1.1 5.5 3.1 MKKS BBS6 ENSG00000125863 "McKusick-Kaufman syndrome" Q9NPJ1 20 10401009-10434222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Chaperone "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041071, HPA044233" Enhanced Supported Centrosome Centrosome "HPA041071: AB_10960408, HPA044233: AB_10962986" "unprognostic (9.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (1.84e-1)" "unprognostic (5.65e-2)" "prognostic unfavourable (9.84e-5)" "unprognostic (5.54e-2)" "unprognostic (1.19e-1)" "unprognostic (2.58e-1)" "unprognostic (1.01e-2)" "unprognostic (1.85e-1)" "prognostic favourable (3.79e-9)" "unprognostic (3.69e-1)" "unprognostic (6.18e-2)" "unprognostic (1.63e-2)" "unprognostic (3.01e-1)" 13.1 15.9 24.3 11.0 26.8 3.1 15.7 31.0 31.6 18.3 19.6 9.9 18.7 21.8 13.9 18.1 15.0 16.1 16.0 25.3 23.7 22.4 33.2 30.6 12.1 11.9 22.4 21.5 17.5 15.2 27.6 16.1 11.7 21.8 16.3 23.0 11.5 18.7 23.8 29.5 11.3 22.0 17.0 16.8 12.1 13.5 20.6 11.6 8.3 20.1 24.0 12.9 13.2 12.9 15.1 22.6 22.6 22.0 13.5 20.9 20.0 12.0 15.1 12.7 18.9 14.4 11.8 4.7 8.6 8.6 9.8 8.3 5.0 6.7 9.2 3.7 7.3 15.3 15.1 15.8 11.9 1.6 6.6 20.7 4.2 16.2 11.1 13.4 4.8 11.4 26.7 9.8 21.2 8.3 11.6 7.1 12.0 5.4 12.5 11.8 9.5 10.2 8.3 13.2 9.5 15.5 5.9 18.4 12.3 7.3 35.4 18.7 10.0 9.7 4.0 8.7 8.4 10.7 14.5 5.7 20.8 4.7 7.8 14.6 9.3 22.6 22.0 18.8 15.9 19.9 18.6 15.1 18.0 14.2 22.6 10.7 20.9 19.5 10.9 13.5 19.5 17.7 13.5 20.0 24.3 26.8 31.0 31.6 23.7 22.4 22.4 21.5 21.8 11.6 MOGAT3 "DC7, DGAT2L2, MGAT3" ENSG00000106384 "Monoacylglycerol O-acyltransferase 3" Q86VF5 7 101195007-101201021 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 61.6;liver: 16.0" "Group enriched" "Detected in some" 6 "CACO-2: 4.7;Hep G2: 15.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.0;liver cancer: 11.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" HPA011940 Approved Approved Centrosome Centrosome "HPA011940: AB_1854057" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (7.14e-2)" "unprognostic (6.11e-2)" "unprognostic (3.20e-1)" "unprognostic (9.54e-3)" "unprognostic (9.36e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-3)" "unprognostic (1.87e-1)" "unprognostic (1.23e-1)" "unprognostic (9.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.59e-2)" 0.2 0.1 0.2 2.6 0.2 0.4 0.2 0.2 0.2 0.2 17.3 0.2 0.2 19.7 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.1 0.9 16.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.1 61.6 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.2 5.3 0.9 1.9 1.2 0.3 0.6 0.2 0.2 0.5 0.0 0.1 0.4 0.6 0.0 0.0 0.0 4.7 1.1 0.3 0.6 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.6 0.6 15.8 0.2 0.5 0.6 0.1 0.1 0.0 0.1 0.1 0.2 0.6 0.1 0.3 0.3 0.5 0.2 0.6 0.3 0.1 0.4 0.7 0.6 0.3 0.3 0.3 0.6 0.1 0.3 0.3 0.8 0.9 0.2 1.0 0.5 0.4 0.2 0.1 1.7 0.6 1.4 2.2 0.9 1.1 1.0 0.7 0.7 1.0 0.8 0.7 0.5 1.7 0.9 1.2 5.3 1.9 0.6 1.2 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 MTMR1 ENSG00000063601 "Myotubularin related protein 1" Q13613 X 150692971-150765103 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002977, HPA018502" Approved Approved Centrosome Centrosome "HPA002977: , HPA018502: AB_1854185" "unprognostic (2.37e-2)" "unprognostic (1.64e-3)" "unprognostic (2.07e-1)" "unprognostic (1.05e-2)" "unprognostic (4.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.97e-1)" "unprognostic (1.34e-1)" "unprognostic (4.35e-2)" "unprognostic (3.16e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-2)" "unprognostic (1.67e-2)" "unprognostic (1.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.19e-1)" "unprognostic (8.40e-2)" 6.9 6.8 20.4 14.0 17.9 9.9 11.8 14.5 15.6 8.3 8.6 8.7 7.2 8.3 9.4 9.2 19.7 9.3 9.0 12.0 17.8 13.4 8.1 10.2 9.7 18.7 12.1 11.5 7.4 11.7 16.3 10.2 37.9 8.8 10.8 9.1 7.9 12.1 13.0 22.2 19.8 10.9 8.3 8.2 18.0 9.7 11.0 9.3 32.6 9.6 10.7 23.1 10.4 7.7 3.3 7.8 7.4 1.5 6.2 4.8 1.8 12.9 8.3 9.0 7.3 2.1 2.4 12.1 11.5 14.9 11.8 16.7 8.0 10.3 28.4 17.1 9.3 11.8 18.1 16.8 18.4 11.5 10.9 1.8 13.0 3.4 6.2 8.3 6.2 6.7 11.7 12.9 0.2 7.1 5.4 7.3 8.4 11.1 12.1 2.1 4.1 12.6 6.5 14.3 12.5 9.2 14.9 13.4 8.4 4.4 9.9 3.7 12.6 4.7 8.9 7.8 6.2 1.0 17.1 9.4 9.6 43.2 1.5 5.4 5.9 0.0 0.9 7.4 3.5 1.5 2.6 2.7 3.9 3.2 2.2 3.3 3.5 4.7 2.4 6.2 1.3 7.8 4.8 1.8 20.4 17.9 14.5 15.6 17.8 13.4 12.1 11.5 8.8 9.3 MTMR11 CRA ENSG00000014914 "Myotubularin related protein 11" A4FU01 1 149928651-149936869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0" "Group enriched" "Detected in many" 37 "dendritic cells: 4.2;monocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030351 Approved Approved Centrosome Centrosome "HPA030351: AB_10602185" "unprognostic (1.14e-1)" "unprognostic (3.01e-3)" "unprognostic (1.42e-1)" "unprognostic (1.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.37e-2)" "unprognostic (5.81e-2)" "unprognostic (7.94e-2)" "unprognostic (2.98e-1)" "unprognostic (2.88e-2)" "unprognostic (1.22e-1)" "unprognostic (5.83e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (1.80e-2)" "unprognostic (9.12e-2)" 3.2 12.0 4.9 15.0 8.4 0.0 5.4 1.5 3.9 9.5 36.8 2.7 5.8 15.9 10.0 6.2 4.4 7.2 17.0 3.1 2.6 2.8 9.7 1.8 3.4 1.5 2.0 2.8 14.5 2.2 5.8 6.3 9.6 5.2 5.5 20.8 4.5 2.1 6.5 1.1 7.4 49.9 11.4 5.0 1.8 4.0 4.9 2.5 0.0 1.6 4.0 1.5 5.8 6.8 0.0 4.2 0.0 3.2 0.0 0.0 0.5 2.6 6.4 2.8 2.3 8.4 9.5 5.2 2.7 9.2 3.6 4.5 0.1 11.6 0.0 6.3 9.4 3.7 0.3 4.6 2.0 0.2 0.0 0.0 1.9 0.8 2.1 0.0 0.0 5.8 1.5 3.6 6.0 4.3 0.1 0.1 7.0 8.6 0.0 0.1 0.6 2.3 0.0 1.0 0.1 5.4 0.8 0.1 0.2 1.6 2.5 0.9 2.8 0.0 2.9 3.9 4.9 3.3 2.1 0.3 1.1 0.0 3.7 0.0 0.3 0.0 1.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 4.9 8.4 1.5 3.9 2.6 2.8 2.0 2.8 5.2 2.5 NLRC5 "CLR16.1, FLJ21709, NOD27" ENSG00000140853 "NLR family CARD domain containing 5" Q86WI3 16 56989485-57083531 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 40.7;NB-4: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA059120, HPA060405" Enhanced Centrosome Centrosome "HPA059120: , HPA060405: " "unprognostic (9.66e-2)" "prognostic favourable (9.69e-4)" "unprognostic (1.64e-2)" "unprognostic (1.23e-2)" "unprognostic (3.12e-1)" "unprognostic (9.27e-3)" "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "unprognostic (2.24e-2)" "prognostic favourable (2.30e-4)" "unprognostic (2.69e-1)" "unprognostic (3.46e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (2.99e-2)" "unprognostic (3.91e-2)" "unprognostic (5.06e-2)" "unprognostic (2.75e-3)" 10.0 5.7 3.4 26.4 7.0 24.9 6.0 1.6 6.2 5.4 7.0 4.2 2.9 4.9 10.8 4.4 6.4 4.9 8.9 3.7 4.3 2.4 5.5 5.5 12.8 21.3 7.0 2.0 3.9 3.6 2.1 20.2 2.3 6.0 5.2 5.6 4.7 8.9 3.0 3.5 10.9 16.1 5.8 7.8 24.6 7.2 1.3 6.3 9.4 5.9 6.6 29.7 7.3 7.0 5.4 1.7 13.2 4.0 2.7 7.0 2.7 4.8 0.9 0.1 0.3 0.3 1.6 0.0 2.7 4.2 8.6 8.4 0.0 8.4 9.9 2.0 4.4 3.2 1.1 0.3 1.0 0.4 0.3 40.7 8.6 0.9 3.0 1.4 2.4 3.2 0.1 7.0 0.7 3.3 0.0 2.0 1.8 0.1 2.2 22.3 0.0 0.9 10.6 3.1 4.1 0.9 0.4 0.3 0.3 5.4 0.5 1.1 0.6 5.3 4.2 4.1 1.4 15.1 2.2 4.0 2.1 10.1 7.4 3.0 0.7 6.4 4.0 13.2 7.0 2.2 4.2 5.4 4.0 6.6 1.7 3.1 2.6 2.7 9.8 2.7 2.5 1.3 4.6 2.7 3.4 7.0 1.6 6.2 4.3 2.4 7.0 2.0 6.0 6.3 OAS2 ENSG00000111335 "2'-5'-oligoadenylate synthetase 2" P29728 12 112978395-113011723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 70.9;BJ hTERT+ SV40 Large T+ RasG12V: 57.8;SK-MEL-30: 27.7;U-266/70: 25.8;U-266/84: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA003320, CAB024984" Approved Approved Centrosome Centrosome "CAB024984: , HPA003320: " "unprognostic (2.39e-1)" "unprognostic (9.51e-2)" "unprognostic (2.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.34e-1)" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (7.64e-3)" "prognostic unfavourable (4.63e-4)" "unprognostic (4.20e-1)" "prognostic unfavourable (4.31e-6)" "unprognostic (1.12e-1)" "unprognostic (4.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.94e-2)" 37.9 3.8 4.0 13.9 5.1 9.0 7.2 1.8 4.9 8.5 4.3 7.5 1.2 4.6 9.0 6.9 13.2 3.9 9.6 6.9 3.8 4.4 8.8 9.9 15.6 24.1 5.0 3.7 3.9 1.9 1.2 2.9 22.2 7.3 6.6 4.7 6.9 32.9 1.8 2.2 2.9 8.8 6.4 7.1 36.6 9.7 2.2 3.0 32.4 9.8 8.2 27.4 13.7 5.4 12.0 12.7 2.0 26.8 15.1 17.4 13.2 0.7 0.1 0.0 0.0 0.3 2.6 0.0 0.1 8.0 70.9 57.8 0.1 1.2 17.8 1.7 1.5 0.8 0.1 0.2 2.5 4.4 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 1.3 4.0 0.0 1.1 0.0 9.3 0.0 0.3 0.5 1.0 0.0 2.5 3.8 0.0 2.7 0.0 6.3 0.0 0.0 0.7 0.2 27.7 0.6 1.1 1.8 0.1 0.0 0.3 0.0 25.8 22.2 2.8 0.6 0.9 0.6 2.0 15.9 1.2 13.4 26.8 16.8 12.0 15.4 15.2 12.7 8.9 15.2 11.2 1.8 15.1 26.0 5.3 17.4 13.2 4.0 5.1 1.8 4.9 3.8 4.4 5.0 3.7 7.3 3.0 OBSL1 KIAA0657 ENSG00000124006 "Obscurin like 1" O75147 2 219550729-219571859 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 82.2" "Cell line enhanced" "Detected in many" "BEWO: 45.2;SK-BR-3: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.8;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 10 "dendritic cells: 2.7;granulocytes: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036404, HPA036405" Approved Approved Centrosome Centrosome "HPA036404: AB_10670437, HPA036405: " "unprognostic (2.36e-1)" "unprognostic (6.79e-2)" "unprognostic (3.86e-2)" "unprognostic (6.57e-2)" "prognostic unfavourable (6.41e-4)" "unprognostic (7.27e-3)" "unprognostic (2.89e-2)" "unprognostic (9.89e-2)" "unprognostic (4.22e-3)" "unprognostic (1.25e-1)" "unprognostic (4.21e-3)" "unprognostic (7.00e-2)" "unprognostic (3.95e-2)" "unprognostic (3.62e-2)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (2.16e-1)" 10.7 26.9 13.4 7.0 11.5 1.2 11.7 18.0 16.2 17.6 8.7 10.3 10.5 3.8 18.2 23.3 7.3 19.9 14.5 30.7 12.8 8.2 19.6 14.5 9.3 3.4 5.5 10.9 82.2 35.6 23.5 16.6 19.3 11.5 15.1 2.3 19.1 25.5 19.1 21.0 14.8 4.8 10.5 8.8 8.2 10.3 15.5 11.5 0.8 34.1 12.4 2.6 10.1 12.1 0.1 2.7 6.8 0.4 0.1 0.2 0.0 9.5 6.5 11.9 24.8 8.3 6.1 45.2 7.2 10.6 9.2 8.6 5.6 15.0 0.0 15.3 9.8 9.8 9.2 5.4 1.9 0.0 16.1 20.8 6.2 28.4 6.2 0.5 0.1 16.5 4.5 2.1 3.5 1.0 8.5 0.2 6.5 23.7 0.0 5.9 28.3 6.7 10.6 10.5 0.0 16.7 9.1 5.2 17.9 8.2 43.9 16.5 4.0 18.0 2.4 9.8 10.6 3.1 2.8 0.0 0.0 0.0 5.7 0.0 9.7 6.8 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.8 0.1 0.4 2.7 0.0 0.0 13.4 11.5 18.0 16.2 12.8 8.2 5.5 10.9 11.5 11.5 ODF2 "CT134, ODF84" ENSG00000136811 "Outer dense fiber of sperm tails 2" Q5BJF6 9 128455186-128501292 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 101.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001874, HPA048841" Enhanced Supported Centrosome Centrosome "HPA001874: AB_1079522, HPA048841: " "unprognostic (4.54e-3)" "unprognostic (9.91e-2)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (6.11e-2)" "unprognostic (2.25e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (1.88e-1)" "unprognostic (1.79e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "prognostic unfavourable (1.72e-4)" "unprognostic (1.93e-2)" "unprognostic (9.23e-3)" "unprognostic (1.47e-1)" "unprognostic (1.62e-1)" "unprognostic (7.65e-2)" 6.2 4.8 5.6 9.9 6.7 10.2 7.0 14.3 7.7 7.1 5.7 6.7 5.4 4.0 9.7 6.4 5.2 8.8 5.7 5.7 6.3 5.1 4.7 6.7 5.8 8.9 6.2 4.1 6.4 5.1 7.6 18.2 6.0 7.5 6.6 6.0 5.4 5.3 8.3 3.7 7.2 5.3 8.0 5.2 7.3 5.7 101.1 7.1 18.4 5.5 3.7 9.6 6.4 6.4 8.3 8.8 16.0 16.3 11.0 14.6 9.1 14.5 17.7 29.6 33.6 11.8 14.2 23.8 24.6 11.5 20.5 10.8 17.4 10.8 26.2 9.3 19.9 38.4 21.5 14.6 20.9 17.3 10.0 23.3 26.8 14.5 6.8 25.1 29.4 11.6 9.3 21.7 15.4 17.8 27.4 14.8 19.3 44.7 26.6 30.7 11.5 12.8 24.4 28.5 20.3 10.6 11.3 17.8 15.2 23.0 22.1 8.0 20.6 18.3 16.9 25.6 15.8 29.4 23.8 27.7 39.8 18.9 11.7 22.9 22.2 16.0 8.9 9.8 12.4 13.4 14.6 8.3 10.9 12.9 8.8 8.2 7.9 10.0 3.1 11.0 16.3 8.4 8.0 9.1 5.6 6.7 14.3 7.7 6.3 5.1 6.2 4.1 7.5 7.1 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7;THP-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome Centrosome "HPA057442: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAFAH1B1 "LIS1, MDCR, MDS, NudF, PAFAH" ENSG00000007168 "Platelet activating factor acetylhydrolase 1b regulatory subunit 1" P43034 17 2593210-2685615 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport" "Developmental protein" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004489, HPA020036" Approved Supported Centrosome 1100000 Centrosome "CAB004489: AB_627889, HPA020036: AB_1854925" "unprognostic (1.54e-3)" "unprognostic (6.84e-2)" "unprognostic (2.10e-1)" "unprognostic (2.51e-1)" "unprognostic (2.13e-1)" "unprognostic (3.19e-3)" "unprognostic (3.17e-2)" "unprognostic (6.36e-2)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" "unprognostic (3.89e-3)" "unprognostic (5.80e-2)" "prognostic favourable (3.16e-4)" "unprognostic (3.31e-1)" "unprognostic (3.51e-1)" "unprognostic (7.45e-2)" "unprognostic (5.58e-2)" 20.1 20.4 35.6 17.0 40.8 10.0 20.8 57.1 63.7 22.3 21.5 24.2 13.8 19.2 23.8 21.1 21.9 20.1 19.6 28.8 33.7 38.3 24.7 17.2 23.0 18.2 34.3 47.0 22.4 16.4 37.5 26.2 20.2 46.5 20.9 20.9 14.8 17.6 24.1 41.6 27.2 21.9 27.2 29.9 17.9 19.3 37.2 28.0 25.9 26.9 17.3 22.8 18.6 25.5 7.5 3.5 9.3 5.3 8.7 13.3 3.9 22.1 21.1 32.6 12.1 25.7 30.4 17.0 30.8 27.0 26.9 27.8 25.7 10.3 25.0 25.7 38.0 23.1 28.5 23.0 33.7 20.9 18.1 20.3 21.5 9.8 26.6 14.1 35.7 26.5 29.3 27.1 32.3 23.5 15.0 28.2 33.1 9.1 22.2 10.5 14.6 10.3 15.9 25.2 12.9 23.6 12.4 14.7 24.1 26.7 13.3 24.3 14.2 11.0 33.2 29.5 14.2 23.1 26.5 12.0 18.5 19.6 23.8 13.1 28.4 7.8 3.4 6.5 7.7 4.3 9.7 7.5 10.1 8.3 3.5 5.2 9.5 8.1 9.3 8.7 5.3 2.7 13.3 3.9 35.6 40.8 57.1 46.2 33.7 38.3 34.3 47.0 46.5 28.0 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364311-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 42.1;lymphoid tissue: 78.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "T-reg: 24.2" "Lineage enriched" "Detected in many" 5 "T-cells: 24.2" HPA047929 Supported Centrosome Centrosome "HPA047929: " "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavourable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavourable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.1 1.8 0.7 24.5 0.8 42.1 2.6 0.4 0.8 1.8 7.7 0.6 1.0 4.6 1.6 2.8 18.8 0.6 4.0 2.2 0.8 1.0 2.5 3.0 4.0 21.8 1.4 0.4 0.9 1.4 0.1 0.6 5.1 0.7 1.6 10.1 0.5 3.1 0.4 0.9 2.8 8.1 1.6 1.9 10.9 4.9 3.0 0.5 78.3 1.2 18.0 20.7 4.3 5.7 2.2 3.2 2.0 0.4 5.2 24.2 2.7 30.4 35.2 30.0 19.1 3.1 11.3 21.9 23.5 20.9 45.3 65.8 39.5 29.0 58.5 8.4 11.9 22.9 74.7 18.2 51.3 37.1 26.8 57.3 37.1 34.0 0.3 37.7 21.2 3.8 1.9 35.8 7.2 34.4 35.2 21.5 52.1 35.1 45.6 84.6 11.1 15.3 59.6 56.8 38.4 21.5 31.5 2.9 15.4 18.6 14.8 10.8 20.9 52.4 4.8 22.5 47.2 27.2 62.7 11.7 40.6 36.6 9.3 83.2 15.1 2.0 0.2 1.2 1.6 0.1 0.2 2.2 4.8 4.5 3.2 0.5 0.4 0.8 1.6 5.2 0.4 0.2 24.2 2.7 0.7 0.8 0.4 0.8 0.8 1.0 1.4 0.4 0.7 0.5 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324122-46445769 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 82.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 10.7" "Group enriched" "Detected in many" 6 "dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Enhanced Enhanced Centrosome Centrosome "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: " "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 4.7 4.7 16.6 6.9 20.4 12.6 3.6 8.3 16.5 3.2 4.0 4.4 3.8 3.7 3.7 4.1 5.1 3.4 5.0 8.2 12.0 4.2 3.2 4.4 4.3 6.4 7.0 9.7 4.9 3.3 5.9 8.0 3.4 5.6 4.0 4.1 2.0 4.1 4.1 82.3 10.4 4.0 4.2 4.3 5.5 4.6 14.5 9.7 9.1 4.4 2.2 4.8 4.7 5.1 0.4 5.3 4.9 1.2 0.5 10.7 2.3 9.2 7.3 11.3 6.9 5.7 5.8 7.1 7.2 5.0 7.2 6.4 8.8 6.0 9.3 4.6 8.2 6.7 9.1 6.2 5.0 27.0 12.8 24.6 13.6 6.8 1.9 12.4 10.2 3.1 4.7 9.6 4.8 5.5 12.4 14.0 9.8 15.4 12.2 12.8 11.2 5.0 15.2 4.6 8.1 5.6 10.0 13.9 6.2 15.5 9.7 4.7 9.2 9.7 7.5 12.9 6.5 7.3 11.4 12.1 10.1 10.0 8.0 12.2 6.9 4.9 0.8 1.3 2.0 0.6 5.9 0.4 0.9 5.9 2.3 0.2 0.7 10.7 0.5 0.5 1.2 5.3 0.9 2.3 16.6 20.4 8.3 16.5 12.0 4.2 7.0 9.7 5.6 9.7 PLEKHH1 KIAA1200 ENSG00000054690 "Pleckstrin homology, MyTH4 and FERM domain containing H1" Q9ULM0 14 67533301-67589612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0;thyroid gland: 30.2" "Cell line enhanced" "Detected in many" "AN3-CA: 9.9;BEWO: 9.6;RT4: 9.7;SK-MEL-30: 12.0;T-47d: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047707, HPA051964" Uncertain Approved Centrosome Centrosome "HPA047707: , HPA051964: " "unprognostic (2.47e-2)" "unprognostic (9.57e-2)" "unprognostic (3.94e-2)" "prognostic favourable (8.03e-5)" "unprognostic (4.74e-1)" "unprognostic (9.15e-3)" "unprognostic (8.43e-5)" "unprognostic (1.54e-2)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.85e-1)" "prognostic favourable (4.03e-7)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favourable (2.26e-4)" 1.3 4.5 9.7 1.6 33.7 0.5 2.9 8.6 26.8 3.5 6.8 61.0 2.5 11.6 1.9 8.9 1.6 3.8 2.5 1.1 16.2 8.7 2.7 0.8 1.2 0.6 35.8 16.6 0.6 7.7 10.3 3.3 2.0 26.9 10.7 7.0 5.1 20.3 2.9 1.1 4.1 9.0 1.3 38.1 1.3 6.6 2.3 34.4 0.0 30.2 0.0 0.7 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.2 2.0 9.9 0.2 0.0 9.6 0.0 0.0 0.1 0.1 3.1 1.5 0.0 1.6 0.0 2.2 3.5 0.8 0.1 0.3 3.4 0.0 1.6 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 3.7 0.0 0.0 7.1 0.0 0.2 3.0 0.6 0.1 0.3 1.4 1.1 9.7 2.7 2.5 0.8 1.8 12.0 9.5 2.0 0.0 0.8 3.6 0.9 0.6 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 33.7 8.6 18.1 16.2 8.7 35.8 16.6 26.9 34.4 POFUT1 "FUT12, KIAA0180, O-Fuc-T, O-FUT" ENSG00000101346 "Protein O-fucosyltransferase 1" Q9H488 20 32207880-32238667 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "monocytes: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054519, HPA059935" Approved Approved Centrosome "Intracellular and membrane" 140000 Centrosome "HPA054519: , HPA059935: " "unprognostic (6.61e-2)" "unprognostic (4.10e-3)" "unprognostic (8.83e-2)" "unprognostic (5.51e-3)" "unprognostic (6.90e-2)" "unprognostic (1.62e-1)" "unprognostic (4.65e-1)" "unprognostic (8.51e-2)" "unprognostic (1.84e-1)" "unprognostic (5.57e-2)" "unprognostic (3.01e-1)" "unprognostic (2.19e-1)" "unprognostic (6.76e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.03e-2)" "unprognostic (5.86e-3)" 15.9 13.5 8.2 15.5 8.9 7.4 19.4 6.6 11.3 15.5 20.2 13.1 10.4 16.4 18.1 19.6 13.9 17.4 23.6 20.1 7.5 6.3 18.8 44.6 14.8 22.2 8.8 6.6 18.3 24.6 19.2 11.3 22.4 7.8 16.0 16.0 16.9 13.3 16.0 13.5 13.3 27.5 20.8 7.7 12.4 12.5 16.5 7.0 12.7 20.1 13.9 13.0 15.7 12.6 2.8 3.9 3.3 16.4 1.7 3.3 3.2 15.0 12.1 10.5 11.5 18.1 17.7 19.7 15.6 18.6 26.4 17.4 36.2 20.4 10.2 23.6 17.4 16.8 10.1 19.3 23.0 5.2 6.3 15.2 11.1 16.4 14.1 13.0 9.7 15.5 15.3 20.0 13.1 14.7 11.4 5.8 18.4 7.4 8.9 10.0 5.4 19.7 7.5 28.0 9.4 8.1 10.0 6.9 8.9 35.9 10.0 13.3 14.8 15.6 12.7 38.4 14.3 24.0 26.5 7.2 9.1 9.4 23.2 45.3 24.2 3.3 4.4 2.1 2.9 12.8 3.3 2.8 2.6 2.7 3.9 2.4 3.3 2.4 0.9 1.7 16.4 2.9 2.7 3.2 8.2 8.9 6.6 11.3 7.5 6.3 8.8 6.6 7.8 7.0 RAB22A ENSG00000124209 "RAB22A, member RAS oncogene family" Q9UL26 20 58309696-58367507 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058894, HPA066920" Approved Uncertain Centrosome Centrosome "HPA058894: , HPA066920: " "unprognostic (4.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.68e-1)" "unprognostic (8.34e-3)" "unprognostic (6.20e-2)" "unprognostic (2.53e-1)" "prognostic unfavourable (7.33e-5)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.12e-1)" "unprognostic (2.00e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (7.01e-3)" 12.4 19.3 19.1 9.5 21.5 7.7 12.4 11.9 23.0 12.8 13.2 15.9 5.9 13.0 11.5 15.3 19.3 9.3 10.7 8.6 17.6 17.0 14.2 13.6 11.1 9.9 16.5 10.3 11.3 10.4 27.7 15.1 11.3 18.1 10.4 13.1 6.8 11.3 11.2 7.8 13.8 17.3 11.1 17.1 10.9 12.7 9.9 13.4 11.8 16.0 11.6 12.9 10.7 12.6 4.3 3.6 5.2 5.1 5.8 6.3 2.1 11.0 4.6 5.8 3.8 12.1 11.4 3.4 8.4 9.7 11.6 7.0 7.6 7.7 6.1 10.5 11.7 8.9 3.0 13.2 13.2 4.1 2.9 4.3 6.5 6.0 9.4 5.3 7.6 7.7 16.2 8.2 8.5 7.2 3.7 8.8 12.0 15.8 6.2 5.0 1.4 11.4 3.3 5.7 5.3 7.2 7.1 4.4 6.0 11.8 22.4 9.7 8.2 7.3 11.4 19.2 7.9 11.9 10.0 7.7 10.5 4.1 19.7 5.1 6.5 3.1 2.9 2.1 6.3 3.3 5.8 4.3 4.7 5.4 3.6 3.8 4.4 5.3 5.2 5.8 5.1 2.9 3.8 2.1 19.1 21.5 11.9 23.0 17.6 17.0 16.5 10.3 18.1 13.4 RGL4 Rgr ENSG00000159496 "Ral guanine nucleotide dissociation stimulator like 4" Q8IZJ4 22 23688136-23699176 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.3;bone marrow: 55.8" "Group enriched" "Detected in many" 5 "MOLT-4: 14.8;U-937: 34.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "neutrophil: 81.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 81.3" HPA035979 Uncertain Approved Centrosome "Intracellular and membrane" Centrosome "HPA035979: AB_10673227" "unprognostic (1.48e-4)" "unprognostic (2.75e-4)" "unprognostic (4.44e-2)" "unprognostic (1.11e-4)" "unprognostic (3.10e-1)" "unprognostic (2.93e-4)" "unprognostic (4.92e-2)" "unprognostic (2.06e-2)" "unprognostic (2.78e-1)" "unprognostic (3.11e-1)" "unprognostic (4.25e-2)" "unprognostic (3.80e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-3)" 1.6 1.0 0.5 9.8 0.6 55.8 0.6 1.0 0.8 0.4 1.0 0.2 0.0 1.3 1.0 1.0 1.1 1.2 1.8 10.8 0.5 0.5 0.8 1.5 6.7 19.9 0.6 0.0 1.4 1.0 0.0 0.7 0.8 0.5 0.5 0.2 0.4 2.2 0.0 0.8 1.9 4.1 0.0 0.6 21.6 0.9 18.4 0.3 11.1 1.0 0.3 8.9 1.1 3.6 0.9 0.8 81.3 12.0 4.8 17.8 5.8 0.9 0.3 3.4 1.5 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.7 0.6 1.1 0.2 0.0 1.6 0.0 0.0 0.0 1.1 2.1 0.5 1.2 0.2 0.0 1.9 2.3 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.5 14.8 2.1 0.2 0.4 5.3 1.2 0.8 0.0 1.0 1.0 1.6 1.0 2.2 0.3 0.7 1.1 1.4 1.9 1.2 1.3 0.6 3.1 0.5 0.7 1.1 34.8 0.9 11.8 0.4 58.6 9.5 2.9 9.8 0.9 12.4 10.9 0.8 0.7 17.8 15.9 81.3 4.8 12.0 0.1 17.0 5.8 0.5 0.6 1.0 0.5 0.5 0.5 0.6 0.0 0.5 0.3 RSPH1 "CILD24, FLJ32753, RSP44, RSPH10A, TSGA2" ENSG00000160188 "Radial spoke head 1 homolog" Q8WYR4 21 42472486-42496354 "Disease related genes, Predicted intracellular proteins" Meiosis "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.4;fallopian tube: 85.5" "Cell line enhanced" "Detected in some" "HEL: 5.4;MCF7: 10.8;RPTEC TERT1: 16.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 6.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016816, HPA017382" Enhanced Supported Centrosome Centrosome "HPA016816: AB_1858393, HPA017382: AB_1858392" "unprognostic (1.76e-3)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.12e-3)" "unprognostic (5.48e-2)" "unprognostic (2.43e-1)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-1)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (1.10e-2)" "unprognostic (8.41e-2)" "unprognostic (2.58e-2)" "unprognostic (5.22e-3)" "unprognostic (1.99e-1)" 0.6 2.5 11.5 0.9 16.4 0.7 1.7 1.2 4.7 4.5 2.6 15.9 3.1 4.5 3.6 22.5 1.0 85.5 3.8 0.6 11.6 15.0 3.8 0.8 17.4 0.7 4.8 4.5 12.9 2.2 4.8 21.4 0.6 38.4 2.2 2.5 1.0 0.9 2.4 0.9 2.4 4.1 1.1 4.6 0.6 3.4 21.9 7.7 0.2 4.8 0.0 0.7 1.5 0.2 0.6 6.7 0.5 0.3 0.0 0.3 0.3 1.6 1.2 0.1 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 3.5 0.1 0.6 0.0 2.0 0.0 0.5 0.0 0.2 0.1 5.4 0.5 0.0 0.0 0.1 0.2 0.3 1.0 0.0 0.1 0.0 0.0 0.3 0.0 10.8 0.1 0.2 0.3 0.5 0.0 0.4 0.0 16.2 1.3 2.5 1.0 2.6 3.9 0.3 4.4 0.4 0.2 0.0 0.1 0.1 0.0 0.5 2.5 0.1 0.1 0.0 0.0 0.1 0.3 0.5 0.3 0.2 0.1 0.4 0.3 0.3 0.3 0.6 0.3 0.2 0.2 0.0 0.1 6.7 0.2 0.3 11.5 16.4 1.2 4.7 11.6 15.0 4.8 4.5 38.4 7.7 SDCCAG8 "BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7" ENSG00000054282 "Serologically defined colon cancer antigen 8" Q86SQ7 1 243256034-243500092 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025737, HPA044477, HPA072495" Approved Enhanced Centrosome Centrosome "HPA025737: , HPA044477: , HPA072495: " "unprognostic (4.12e-1)" "unprognostic (3.94e-2)" "unprognostic (7.58e-2)" "unprognostic (2.86e-2)" "unprognostic (2.61e-1)" "unprognostic (3.78e-2)" "unprognostic (9.34e-2)" "unprognostic (3.95e-2)" "unprognostic (4.37e-2)" "unprognostic (5.97e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-2)" "unprognostic (1.38e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (3.68e-3)" "unprognostic (4.69e-2)" 13.5 12.6 17.2 10.0 17.7 7.9 13.0 12.3 17.6 11.4 10.5 22.5 10.4 7.5 13.3 17.7 11.6 17.9 17.6 12.8 16.8 13.5 15.2 7.9 14.8 10.4 17.4 12.0 19.9 17.3 18.0 32.4 11.4 14.2 15.5 8.3 10.7 16.8 13.1 15.1 10.2 9.3 11.3 18.9 15.0 11.0 8.0 20.9 17.4 32.7 7.2 10.4 11.8 10.7 9.8 9.9 9.3 10.7 12.5 8.6 5.2 5.4 4.6 0.7 3.4 5.1 2.9 5.6 3.4 2.9 0.6 1.3 4.5 9.8 2.1 5.7 2.9 1.9 0.6 4.1 1.4 3.5 5.5 1.8 3.4 1.9 3.3 1.7 4.6 6.0 3.9 3.0 6.5 4.2 2.6 3.2 2.5 1.5 0.7 4.3 0.6 7.8 2.8 0.8 1.8 6.1 3.5 4.8 4.8 4.1 2.1 7.8 3.6 2.8 4.2 5.9 1.3 1.8 1.9 4.4 2.2 1.0 2.8 3.8 25.9 9.3 10.7 9.0 6.0 10.5 3.8 7.5 6.4 7.8 9.9 9.8 8.6 6.5 6.9 12.5 5.7 7.9 5.0 5.2 17.2 17.7 12.3 17.6 16.8 13.5 17.4 12.0 14.2 20.9 SEC14L4 "dJ130H16.5, TAP3" ENSG00000133488 "SEC14 like lipid binding 4" Q9UDX3 22 30488913-30505711 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 35.8;testis: 13.4" "Cell line enriched" "Detected in some" 4 "BEWO: 28.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 3.1;neutrophil: 2.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 3.0" HPA069748 Approved Centrosome 44000 Centrosome "HPA069748: " "unprognostic (6.98e-4)" "unprognostic (2.72e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.07e-2)" "unprognostic (9.88e-2)" "unprognostic (4.93e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (1.88e-2)" "unprognostic (8.87e-2)" "unprognostic (4.06e-8)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" "unprognostic (5.98e-2)" 0.1 1.1 0.1 0.1 0.1 6.7 0.1 0.2 0.4 0.4 0.2 0.1 0.1 0.0 0.1 1.0 0.3 0.2 0.4 0.1 0.1 0.1 0.3 35.8 8.5 0.1 0.1 0.1 0.2 0.2 6.7 0.2 0.3 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.5 0.4 13.4 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.7 0.5 3.1 0.4 0.4 0.4 0.1 1.7 5.4 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.4 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 3.1 0.4 0.4 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.4 2.6 0.4 0.3 0.5 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 SERPINB6 "CAP, DFNB91, PI6, PTI" ENSG00000124570 "Serpin family B member 6" P35237 6 2948159-2972165 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA009668, HPA012736" Enhanced Approved Centrosome 5100000 Centrosome "HPA009668: AB_1079919, HPA012736: AB_1856729" "unprognostic (3.44e-1)" "unprognostic (1.03e-1)" "unprognostic (8.72e-2)" "unprognostic (1.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.56e-2)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (7.63e-2)" "prognostic favourable (4.81e-4)" "unprognostic (3.51e-1)" "unprognostic (1.54e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (1.59e-1)" "unprognostic (5.08e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 31.6 38.8 21.1 23.5 34.8 17.3 29.6 13.4 20.8 31.8 44.6 35.2 38.1 54.9 30.3 30.3 36.0 35.9 42.4 58.7 21.1 21.3 32.4 20.1 36.2 45.3 33.7 20.4 45.3 85.3 26.5 23.7 38.5 28.5 37.8 30.9 32.6 23.4 32.6 51.0 12.0 85.5 36.6 32.4 41.4 29.9 55.5 28.9 5.9 32.6 34.2 23.7 31.7 24.5 8.4 30.8 34.2 31.3 23.6 18.6 24.0 30.3 19.9 6.6 27.3 17.9 39.9 20.4 28.4 34.5 22.6 26.4 7.0 22.0 0.2 32.8 32.2 46.1 18.2 28.9 21.2 39.9 8.2 17.9 23.8 11.8 31.3 0.3 10.9 22.9 20.3 21.5 5.6 53.4 23.1 0.5 40.1 21.6 0.2 0.3 3.8 38.4 1.9 12.3 25.5 28.4 7.4 0.4 16.8 23.3 3.5 31.5 15.4 14.6 38.2 23.1 8.5 51.2 19.2 0.6 0.1 0.5 17.7 17.9 23.6 13.9 31.3 34.2 16.8 30.4 8.3 8.4 9.5 11.1 30.8 6.9 11.3 18.6 2.8 23.6 24.6 3.1 1.3 24.0 21.1 34.8 13.4 20.8 21.1 21.3 33.7 20.4 28.5 28.9 SLC1A4 "ASCT1, SATT" ENSG00000115902 "Solute carrier family 1 member 4" P43007 2 64988477-65023865 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 71.3;U-266/70: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034963, HPA034964" Approved Enhanced Centrosome Centrosome "HPA034963: , HPA034964: AB_2674386" "unprognostic (7.61e-2)" "prognostic favourable (3.59e-4)" "unprognostic (2.49e-1)" "unprognostic (3.19e-3)" "unprognostic (1.26e-1)" "unprognostic (2.24e-2)" "prognostic unfavourable (4.23e-5)" "unprognostic (1.26e-2)" "unprognostic (2.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.28e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (4.87e-4)" "unprognostic (6.37e-3)" "unprognostic (4.14e-2)" "unprognostic (3.53e-2)" "unprognostic (1.98e-2)" 6.0 20.3 31.4 7.6 34.4 10.3 12.7 8.8 43.1 13.5 8.3 8.1 6.1 5.6 11.7 7.8 6.5 4.7 3.8 5.1 20.6 23.5 1.9 11.1 4.5 8.7 17.1 21.2 12.2 28.4 6.1 10.3 6.0 15.4 9.1 7.8 12.1 5.7 6.9 29.6 15.9 5.1 11.3 5.8 6.3 7.0 7.8 8.5 15.7 5.3 11.5 15.8 5.4 7.8 1.1 8.4 2.0 10.1 5.5 3.9 1.4 3.6 2.8 1.6 8.6 3.7 2.4 2.3 7.0 3.4 2.9 5.0 0.7 0.5 12.0 1.6 10.9 10.6 3.3 0.8 3.0 4.8 1.3 6.2 3.4 7.3 7.9 10.4 5.8 1.1 18.4 3.9 6.1 1.8 4.8 30.3 2.0 3.2 8.8 6.9 1.1 3.4 3.2 0.4 29.7 1.2 1.8 7.3 3.5 4.3 4.0 71.3 4.7 11.5 0.4 4.0 4.8 7.8 4.2 33.3 16.4 29.1 5.9 20.9 21.2 0.0 2.3 2.0 1.0 5.3 1.4 1.1 1.1 1.8 4.4 0.3 0.0 1.0 0.0 5.5 10.1 8.4 3.9 1.4 31.4 34.4 8.8 25.9 20.6 23.5 17.1 21.2 15.4 8.5 SPICE1 "CCDC52, SPICE" ENSG00000163611 "Spindle and centriole associated protein 1" Q8N0Z3 3 113442718-113515187 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064843 Approved Supported Centrosome Centrosome "HPA064843: AB_2685367" "unprognostic (2.66e-1)" "unprognostic (1.27e-2)" "unprognostic (1.12e-1)" "unprognostic (4.95e-3)" "unprognostic (2.69e-1)" "unprognostic (1.01e-1)" "unprognostic (4.99e-3)" "unprognostic (1.17e-1)" "unprognostic (6.30e-2)" "unprognostic (2.24e-1)" "unprognostic (1.17e-3)" "unprognostic (1.89e-2)" "unprognostic (4.75e-3)" "unprognostic (6.53e-2)" "unprognostic (4.47e-1)" "unprognostic (3.64e-3)" "unprognostic (2.95e-2)" 8.1 6.3 9.3 13.4 8.6 6.1 11.7 17.8 8.4 14.0 9.6 8.1 20.6 6.4 16.3 9.8 10.2 13.5 11.1 8.3 8.9 4.9 7.8 7.7 11.5 6.6 7.1 7.6 15.3 11.2 12.5 40.4 7.7 8.6 11.6 10.9 7.8 15.0 19.6 5.1 10.2 8.9 11.3 9.9 6.8 10.5 10.5 8.9 17.1 12.9 4.7 10.7 13.2 14.4 8.5 12.0 4.5 5.4 3.2 9.3 2.5 16.0 10.6 13.2 11.3 8.1 9.9 9.3 8.4 5.8 10.2 12.9 8.9 9.5 10.1 10.7 6.9 15.6 6.8 7.9 14.3 6.2 3.6 9.4 10.7 6.2 4.1 17.1 7.1 6.9 7.8 10.6 4.8 7.5 5.7 8.7 4.3 16.7 14.6 8.1 12.9 12.7 11.2 9.8 8.0 4.5 11.3 7.2 12.2 9.0 9.2 5.5 10.4 8.2 7.3 7.4 9.9 5.0 7.1 8.6 5.6 14.4 11.3 10.2 8.3 4.5 5.4 1.9 4.5 3.7 6.9 7.3 6.7 5.2 3.7 8.5 9.3 6.9 2.8 3.2 3.4 12.0 3.2 2.5 9.3 8.6 17.8 8.4 8.9 4.9 7.1 7.6 8.6 8.9 ST7L "FAM4B, FLJ20284, ST7R, STLR" ENSG00000007341 "Suppression of tumorigenicity 7 like" Q8TDW4 1 112523518-112620825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042324, HPA075418" Uncertain Approved Centrosome Centrosome "HPA042324: AB_10794273, HPA075418: " "unprognostic (2.99e-2)" "unprognostic (1.07e-2)" "prognostic favourable (8.34e-5)" "prognostic unfavourable (8.96e-4)" "unprognostic (3.30e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-6)" "unprognostic (2.24e-3)" "prognostic unfavourable (5.16e-4)" "prognostic favourable (3.04e-5)" "unprognostic (2.98e-2)" "unprognostic (6.91e-2)" "unprognostic (5.72e-2)" "unprognostic (4.12e-3)" "unprognostic (3.68e-2)" "unprognostic (3.26e-2)" "unprognostic (3.27e-2)" 7.7 9.3 5.7 5.5 9.0 8.6 8.2 12.1 7.9 8.1 6.9 10.0 7.2 5.5 10.0 7.8 6.1 7.9 6.0 8.6 5.6 5.9 6.3 7.6 5.7 5.3 6.1 5.1 9.4 11.6 5.2 12.8 6.4 6.3 7.3 8.0 9.4 7.0 9.0 10.2 8.9 6.2 7.9 6.4 5.2 5.8 49.0 7.0 4.6 11.8 4.6 5.6 6.8 7.7 4.2 3.5 0.3 2.1 6.9 5.2 1.9 4.8 1.5 8.6 6.1 11.8 11.7 2.1 6.2 4.7 2.6 3.9 2.7 4.8 2.1 2.5 2.5 3.4 10.1 8.0 4.1 3.1 6.0 5.9 7.5 1.8 6.8 4.9 6.3 2.1 2.0 3.1 6.4 8.6 3.4 6.8 10.9 1.9 2.6 1.9 3.9 5.3 4.2 4.5 0.7 5.4 5.9 6.3 3.9 3.3 4.7 4.4 3.5 3.0 8.3 6.1 6.0 7.9 6.0 1.8 1.3 2.1 5.5 8.0 13.4 0.1 1.8 0.2 2.4 2.1 3.9 4.2 3.6 1.8 1.7 1.8 5.2 2.8 0.3 6.9 1.6 3.5 2.4 1.9 5.7 9.0 12.1 7.9 5.6 5.9 6.1 5.1 6.3 7.0 STK32A "MGC22688, YANK1" ENSG00000169302 "Serine/threonine kinase 32A" Q8WU08 5 147234963-147387852 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 19.7;brain: 21.1;retina: 31.9" "Group enriched" "Detected in some" 5 "RT4: 9.6;SK-MEL-30: 33.8" "Cancer enhanced" "Detected in many" "melanoma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040236 Uncertain Approved Centrosome Centrosome "HPA040236: AB_10795416" "unprognostic (1.90e-1)" "unprognostic (4.71e-4)" "unprognostic (5.32e-2)" "unprognostic (3.49e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (2.96e-3)" "unprognostic (4.85e-2)" "unprognostic (2.36e-2)" "unprognostic (3.87e-1)" "unprognostic (8.38e-2)" "unprognostic (2.50e-3)" "unprognostic (5.53e-5)" "unprognostic (2.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.67e-3)" 2.1 19.7 4.8 1.3 7.1 0.4 2.3 21.1 7.7 1.2 1.8 6.2 0.6 1.2 1.6 5.6 1.0 1.3 4.3 1.6 4.9 12.6 6.3 0.6 2.1 0.5 12.1 2.2 5.1 4.2 0.4 8.5 0.7 20.7 2.1 1.1 31.9 1.2 1.8 0.6 2.9 1.1 1.4 12.4 0.8 1.4 2.1 6.9 0.0 15.7 0.5 0.5 4.1 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.1 3.7 9.6 0.9 0.4 0.0 0.1 33.8 0.0 0.0 0.1 0.0 0.6 0.4 0.3 1.1 0.2 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.8 7.1 21.1 2.3 4.9 12.6 12.1 2.2 20.7 6.9 TBC1D31 "Gm85, MGC21654, WDR67" ENSG00000156787 "TBC1 domain family member 31" Q96DN5 8 123041968-123152153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 29.0" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023710 Approved Approved Centrosome Centrosome "HPA023710: AB_1858819" "unprognostic (1.39e-1)" "unprognostic (5.44e-3)" "unprognostic (7.21e-2)" "unprognostic (3.18e-5)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (2.63e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (1.53e-2)" "unprognostic (6.59e-2)" "unprognostic (8.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.18e-4)" "unprognostic (1.78e-3)" "unprognostic (1.57e-1)" "unprognostic (1.76e-2)" "unprognostic (2.33e-1)" 3.8 4.4 6.7 9.7 10.9 7.3 3.6 13.5 7.7 3.2 5.2 4.5 5.2 6.9 3.8 2.4 4.6 7.5 3.6 5.3 7.2 5.7 4.4 3.8 3.9 11.0 5.5 5.6 2.9 5.4 5.5 8.4 2.7 7.5 3.4 6.3 5.6 3.6 4.1 3.7 4.7 5.9 4.8 4.7 7.4 3.9 9.2 4.7 29.0 5.1 5.2 10.3 5.2 4.1 2.4 2.6 3.0 3.3 9.5 16.8 4.0 10.7 4.5 8.1 6.4 2.8 3.1 4.0 5.8 3.5 7.7 7.1 4.3 4.7 5.0 4.5 2.5 7.0 7.8 3.8 10.9 10.3 7.7 11.8 4.9 3.7 4.4 5.4 8.4 2.5 2.3 6.4 6.6 5.5 9.8 12.0 5.5 8.7 16.8 3.6 6.3 7.9 8.2 7.3 5.2 5.2 2.9 7.6 5.9 13.0 39.0 3.9 6.2 4.5 2.9 6.1 12.5 5.0 8.6 9.4 13.6 6.0 5.0 9.8 9.1 2.7 3.1 3.0 8.3 3.3 16.8 2.4 3.8 6.3 2.6 2.3 4.7 5.3 1.6 9.5 1.4 1.6 3.0 4.0 6.7 10.9 13.5 7.7 7.2 5.7 5.5 5.6 7.5 4.7 TMEM170B ENSG00000205269 "Transmembrane protein 170B" Q5T4T1 6 11538278-11583524 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.1" "Cell line enhanced" "Detected in many" "THP-1: 18.3;U-937: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055134 Uncertain Approved Centrosome Centrosome "HPA055134: " "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.71e-4)" "unprognostic (6.67e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (4.62e-3)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (2.45e-5)" "unprognostic (3.49e-1)" "unprognostic (1.26e-1)" "unprognostic (4.27e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-4)" "unprognostic (3.97e-2)" 10.1 4.8 11.7 6.4 9.6 31.1 6.1 13.5 18.6 3.1 3.3 4.9 2.0 1.6 4.1 5.2 2.5 2.8 3.0 4.5 10.1 8.8 5.9 12.8 8.8 3.5 8.3 8.7 3.9 3.3 5.8 4.2 4.0 8.4 3.4 2.2 4.2 2.5 3.7 8.3 1.8 2.0 4.7 8.2 5.7 2.4 5.2 6.0 4.2 4.4 1.2 2.2 2.7 3.1 0.2 3.2 2.4 2.9 0.1 0.3 0.5 0.7 1.2 7.5 6.7 1.4 0.1 1.5 0.6 1.7 1.0 1.2 0.4 0.4 5.9 3.4 0.4 0.0 8.5 0.5 2.7 1.6 4.3 3.3 0.8 1.0 0.5 5.3 3.5 0.5 0.1 1.1 0.0 0.7 0.2 0.1 1.5 1.1 6.3 9.2 2.1 1.0 3.2 7.2 0.9 0.8 1.5 5.1 4.4 0.4 2.4 2.7 2.4 18.3 0.1 1.4 1.6 2.8 1.7 5.2 10.4 5.3 1.2 13.6 1.8 2.4 2.9 1.5 0.2 1.6 0.1 0.0 0.1 0.1 1.8 0.2 0.3 0.2 1.1 0.1 0.6 3.2 0.0 0.5 11.7 9.6 13.5 13.5 10.1 8.8 8.3 8.7 8.4 6.0 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.8;pituitary gland: 21.1" "Cell line enhanced" "Detected in some" "Daudi: 11.6;Karpas-707: 15.6;RPMI-8226: 7.9;SCLC-21H: 21.2;SK-BR-3: 18.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.4 14.1 3.4 1.0 8.4 1.1 5.2 63.8 16.3 1.5 5.8 1.9 0.0 1.8 0.3 6.8 4.8 0.6 0.5 0.3 3.2 9.7 0.7 0.4 0.9 0.6 4.6 6.0 0.4 6.7 1.2 21.1 1.1 6.6 0.4 4.3 0.9 1.3 0.2 0.8 4.4 2.2 1.1 1.8 3.2 3.1 9.9 1.2 0.0 3.2 0.6 0.6 0.3 2.9 0.1 0.7 2.0 1.7 1.7 1.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 11.6 2.2 0.0 1.6 2.4 0.9 0.0 0.7 0.9 0.2 1.1 0.0 0.0 2.0 0.1 0.0 4.9 0.0 0.1 0.0 0.0 15.6 0.0 5.8 1.6 0.1 0.5 0.0 0.0 0.8 7.9 0.2 0.0 21.2 3.2 0.2 18.8 0.0 1.8 1.0 0.0 0.0 4.0 0.0 0.0 1.2 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.5 1.0 0.7 0.1 0.5 0.4 2.0 1.7 1.7 0.0 0.0 0.4 3.4 8.4 63.8 13.0 3.2 9.7 4.6 6.0 6.6 1.2 TRIM2 "CMT2R, KIAA0517, RNF86" ENSG00000109654 "Tripartite motif containing 2" Q9C040 4 153152342-153339320 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0" "Cell line enhanced" "Detected in many" "AF22: 28.1;NTERA-2: 23.1;RPTEC TERT1: 26.3;SK-MEL-30: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 5.4" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035853, HPA035854" Enhanced Approved Centrosome Centrosome "HPA035853: AB_10669533, HPA035854: AB_10669659" "unprognostic (8.94e-2)" "unprognostic (7.89e-2)" "unprognostic (6.21e-3)" "unprognostic (7.51e-3)" "unprognostic (2.07e-2)" "unprognostic (2.32e-1)" "unprognostic (1.16e-2)" "unprognostic (2.30e-3)" "unprognostic (5.30e-2)" "unprognostic (6.77e-2)" "unprognostic (1.93e-2)" "unprognostic (1.42e-2)" "prognostic favourable (6.58e-14)" "unprognostic (5.89e-2)" "unprognostic (1.17e-2)" "unprognostic (4.19e-2)" "unprognostic (4.13e-2)" 4.2 9.9 28.4 4.4 35.7 0.6 12.2 28.9 56.9 19.6 17.8 67.0 5.9 13.5 9.7 15.1 8.5 12.9 10.3 6.2 38.9 25.3 22.1 6.4 5.9 2.3 39.4 34.6 10.9 8.2 1.0 10.9 2.5 45.3 11.5 19.2 4.6 30.1 11.8 1.8 3.8 14.4 6.6 44.2 8.8 23.5 1.9 44.7 0.0 38.9 0.6 4.3 7.6 5.5 1.9 0.8 0.3 0.6 0.3 5.4 0.7 4.7 0.2 28.1 12.3 10.6 12.2 0.4 6.3 8.6 1.8 2.6 2.7 0.3 0.2 4.0 10.9 4.3 13.1 2.4 1.8 0.1 4.9 0.2 2.9 0.6 12.4 0.2 0.1 7.9 1.4 3.6 2.3 1.6 0.2 0.1 2.2 0.4 1.3 0.0 23.1 5.6 0.8 5.1 0.0 26.3 6.2 9.1 17.9 3.0 11.4 25.2 1.2 0.2 2.4 7.9 2.3 6.1 3.0 0.1 0.0 0.1 11.8 0.1 9.7 0.3 0.6 0.1 0.1 0.0 0.0 1.6 5.4 0.1 0.8 1.9 1.6 1.0 0.2 0.3 0.0 0.1 2.6 0.7 28.4 35.7 28.9 41.1 38.9 25.3 39.4 34.6 45.3 44.7 TTC39A "C1orf34, DEME-6, KIAA0452" ENSG00000085831 "Tetratricopeptide repeat domain 39A" Q5SRH9 1 51287258-51345116 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 21.5;MCF7: 16.9;SK-BR-3: 52.6;T-47d: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 23.4" "Lineage enriched" "Detected in single" 46 "dendritic cells: 23.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028098, HPA043440" Uncertain Approved Centrosome Centrosome "HPA028098: AB_10601705, HPA043440: " "unprognostic (5.05e-2)" "unprognostic (1.95e-1)" "unprognostic (3.35e-2)" "unprognostic (7.60e-2)" "unprognostic (8.53e-3)" "unprognostic (2.86e-2)" "prognostic unfavourable (5.05e-5)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (8.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.89e-2)" "unprognostic (1.73e-3)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 1.2 4.9 3.2 6.0 5.5 0.6 23.4 0.7 4.3 8.5 18.0 0.2 8.1 3.3 1.4 10.4 10.4 4.5 17.9 8.3 3.3 7.4 40.4 3.1 12.4 0.5 4.2 2.4 0.9 22.3 6.1 12.1 0.9 10.1 12.3 20.2 3.1 10.1 10.7 2.2 5.6 4.5 0.8 4.9 0.3 18.7 28.2 2.0 0.2 5.5 8.5 6.2 5.0 5.0 0.1 23.4 0.5 0.0 0.0 0.0 0.2 2.2 1.2 0.2 0.1 0.1 0.2 9.3 0.1 0.0 0.0 0.0 5.7 0.9 0.0 4.1 0.1 0.0 1.2 0.0 0.0 21.5 4.3 0.1 0.5 1.1 0.4 0.0 0.2 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 16.9 0.2 0.0 1.6 0.2 0.0 0.0 1.4 9.2 2.9 7.8 0.7 0.1 52.6 0.5 38.1 0.2 0.2 0.1 1.0 0.1 0.1 2.2 2.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 23.4 0.0 0.2 3.2 5.5 0.7 4.3 3.3 7.4 4.2 2.4 10.1 2.0 TTC6 "C14orf25, NCRNA00291" ENSG00000139865 "Tetratricopeptide repeat domain 6" Q86TZ1 14 37595847-38041442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 9.7;prostate: 20.5" "Cell line enhanced" "Detected in some" "Hep G2: 7.2;MCF7: 10.5;RT4: 7.3;T-47d: 20.2" "Group enriched" "Detected in some" 7 "breast cancer: 2.2;prostate cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA069293 Approved Centrosome Centrosome "HPA069293: " "unprognostic (7.92e-2)" "unprognostic (6.95e-2)" "unprognostic (9.22e-2)" "unprognostic (1.98e-1)" "unprognostic (7.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.68e-1)" "unprognostic (3.60e-4)" "unprognostic (6.75e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-4)" "unprognostic (5.60e-2)" "unprognostic (8.91e-8)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-1)" "unprognostic (6.07e-3)" 0.0 0.0 0.3 1.3 0.6 0.0 9.7 0.3 0.6 0.2 2.2 0.2 0.0 0.6 0.0 1.3 0.6 0.4 1.0 0.0 0.8 0.9 0.0 7.9 5.6 0.0 0.7 0.4 0.4 0.0 0.0 1.1 0.3 0.1 20.5 0.5 0.0 3.0 1.1 0.0 0.8 1.2 2.5 0.6 0.0 3.8 6.0 0.0 0.0 0.0 0.6 2.3 2.2 4.6 0.6 0.2 0.4 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.4 0.0 2.1 1.2 0.2 0.0 0.0 3.0 0.0 0.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.0 7.3 2.2 0.0 0.0 4.0 0.0 20.2 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.3 0.6 0.8 0.9 0.7 0.4 0.1 0.0 TTI2 "C8orf41, FLJ23263" ENSG00000129696 "TELO2 interacting protein 2" Q6NXR4 8 33473386-33513601 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023523, HPA029823" Approved Enhanced Centrosome Centrosome "HPA023523: AB_1845776, HPA029823: AB_10602337" "unprognostic (6.30e-2)" "unprognostic (3.09e-2)" "unprognostic (9.34e-3)" "unprognostic (5.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" "unprognostic (4.25e-3)" "unprognostic (2.64e-1)" "unprognostic (3.10e-1)" "unprognostic (2.97e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.07e-2)" "unprognostic (2.05e-1)" "unprognostic (1.94e-1)" "unprognostic (9.35e-2)" 10.7 13.1 8.0 9.7 12.2 12.0 10.7 11.1 13.5 11.0 9.3 11.2 6.4 8.7 11.8 10.9 11.4 10.5 7.3 12.7 9.4 7.5 10.7 14.0 9.3 14.9 10.1 10.5 10.9 9.9 11.7 16.5 9.2 9.6 9.8 9.5 11.4 12.1 8.7 14.8 11.0 10.5 9.8 10.7 14.3 9.7 25.7 9.0 22.9 13.2 7.6 17.1 10.3 10.2 22.1 36.7 19.3 14.6 17.2 19.3 24.0 5.2 9.8 12.8 12.8 9.4 6.8 5.4 7.9 9.0 13.3 13.3 7.5 4.4 15.0 12.0 5.8 9.3 20.5 9.2 11.9 6.7 6.2 8.9 5.8 8.0 10.6 8.2 9.0 5.5 11.8 9.9 9.0 11.5 13.5 11.9 9.2 10.5 24.6 8.6 17.1 6.5 16.8 10.4 7.1 7.3 5.6 15.7 8.3 7.8 7.2 9.6 7.3 6.7 7.5 8.2 7.3 8.5 7.6 6.5 6.3 22.3 8.2 8.3 8.8 10.4 14.1 19.3 15.7 14.0 16.1 19.2 16.0 15.6 11.9 22.1 19.3 18.1 13.0 17.2 14.6 36.7 15.2 24.0 8.0 12.2 11.1 13.5 9.4 7.5 10.1 10.5 9.6 9.0 TUBGCP4 "76P, FLJ14797" ENSG00000137822 "Tubulin gamma complex associated protein 4" Q9UGJ1 15 43369221-43409771 "Disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043212 Approved Supported Centrosome Centrosome "HPA043212: AB_10796690" "unprognostic (1.34e-2)" "unprognostic (3.57e-2)" "unprognostic (4.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (3.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.09e-2)" "unprognostic (2.91e-2)" "unprognostic (5.65e-1)" "unprognostic (1.73e-1)" "unprognostic (7.49e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-1)" 8.2 9.6 10.9 10.4 16.2 9.6 11.6 23.6 19.4 11.6 9.9 9.4 4.3 10.7 11.6 8.4 10.9 10.9 6.8 10.8 9.8 13.1 9.4 12.8 7.9 9.6 11.4 9.2 12.6 15.2 19.4 14.1 8.5 13.3 10.6 12.2 11.8 11.5 9.1 14.6 10.5 9.8 11.4 8.6 8.4 9.1 10.9 11.6 12.6 10.7 8.8 12.1 10.0 9.1 3.9 5.8 14.5 3.3 5.4 4.2 2.5 11.2 3.5 8.6 8.8 8.5 9.2 6.6 6.5 4.7 9.1 9.1 11.3 7.0 7.1 9.9 5.5 18.8 18.0 11.5 10.6 11.7 17.2 18.2 20.1 9.8 7.1 12.5 11.5 5.0 11.6 9.3 13.0 7.3 17.3 6.1 6.6 3.9 10.0 9.7 4.0 14.2 13.6 11.3 10.4 5.9 10.8 23.0 7.9 7.9 15.4 2.7 9.0 9.8 6.0 8.6 8.9 11.8 14.2 6.6 7.5 12.4 8.0 18.2 9.6 0.1 2.7 14.5 4.2 3.3 3.1 3.9 3.2 3.0 5.8 3.6 2.4 3.5 0.3 5.4 1.6 3.1 3.5 2.5 10.9 16.2 23.6 19.4 9.8 13.1 11.4 9.2 13.3 11.6 UBL3 "DKFZP434K151, FLJ32018, HCG-1, PNSC1" ENSG00000122042 "Ubiquitin like 3" O95164 13 29764371-29850684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBF TERT88: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053772, HPA058781" Uncertain Approved Centrosome Centrosome "HPA053772: , HPA058781: " "unprognostic (2.83e-2)" "unprognostic (5.48e-2)" "unprognostic (3.20e-1)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.20e-1)" "unprognostic (3.22e-1)" "unprognostic (3.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "prognostic favourable (4.23e-4)" "unprognostic (8.49e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.84e-1)" 11.9 11.7 27.9 9.1 35.2 10.3 16.7 22.6 32.3 22.9 16.5 28.8 12.2 15.0 24.0 14.8 24.0 15.4 17.5 10.8 32.6 30.5 19.9 22.4 20.2 9.3 36.7 23.6 17.8 30.5 20.6 17.4 13.6 31.2 12.8 15.5 17.1 14.9 13.5 14.7 13.0 17.3 17.5 45.9 12.9 38.4 11.6 30.0 10.8 22.7 8.3 9.9 12.4 15.4 2.7 7.7 8.0 8.4 5.0 23.7 6.3 3.9 2.5 7.9 4.7 11.2 10.8 8.4 32.9 19.4 14.1 11.4 5.9 9.0 3.5 7.4 32.6 4.0 3.6 4.9 40.6 5.4 4.4 3.6 3.4 4.7 3.5 5.3 4.9 6.3 16.0 7.4 4.8 5.0 1.8 2.5 5.9 26.7 3.9 4.5 4.7 3.6 4.6 10.2 3.9 9.2 4.7 9.2 4.6 4.6 16.1 33.1 8.7 9.1 4.3 18.3 4.5 10.0 4.4 5.9 2.3 2.6 6.5 4.6 12.1 5.4 8.2 6.8 8.2 8.0 3.8 2.2 10.4 7.9 7.7 2.7 6.0 7.4 8.0 5.0 8.4 3.6 23.7 6.3 27.9 35.2 22.6 29.7 32.6 30.5 36.7 23.6 31.2 30.0 UBXN2A UBXD4 ENSG00000173960 "UBX domain protein 2A" P68543 2 23927285-24004909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065482, HPA069096" Supported Approved Centrosome Centrosome "HPA065482: , HPA069096: " "unprognostic (5.29e-2)" "unprognostic (1.93e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.86e-2)" "prognostic unfavourable (1.39e-5)" "unprognostic (9.26e-2)" "unprognostic (2.76e-1)" "unprognostic (1.15e-2)" "unprognostic (1.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (8.85e-2)" "unprognostic (2.14e-1)" "unprognostic (4.60e-2)" "unprognostic (6.75e-2)" 12.7 10.6 10.8 8.3 10.7 9.6 13.8 16.7 10.6 9.4 14.0 12.2 9.5 12.1 13.4 9.1 11.7 9.2 8.2 17.7 10.0 11.6 9.1 12.0 10.0 7.8 12.7 8.9 9.3 7.8 17.3 13.6 14.0 13.3 9.9 9.1 11.1 9.9 11.4 24.3 10.3 13.3 14.9 11.3 6.8 8.2 7.3 11.9 9.8 9.4 7.5 9.1 12.0 15.0 6.5 7.3 6.9 4.0 8.6 7.1 2.8 10.5 7.1 9.9 6.7 11.5 10.1 5.0 10.9 7.4 10.7 7.4 5.2 4.8 9.2 3.4 7.0 4.6 9.4 7.8 9.5 18.5 9.0 10.8 5.0 7.8 8.5 6.8 4.9 12.2 6.3 9.4 7.2 6.3 12.1 9.3 9.2 8.1 8.9 4.4 7.8 5.1 12.2 24.5 4.0 4.5 8.4 4.9 11.8 10.5 5.2 13.6 3.0 3.9 10.4 7.7 8.1 7.0 7.0 13.3 14.2 13.2 5.9 6.4 7.7 6.9 4.0 4.4 6.2 2.2 6.8 6.5 6.5 5.9 3.1 5.8 7.1 6.5 4.0 8.6 2.7 7.3 4.7 2.8 10.8 10.7 16.7 10.6 10.0 11.6 12.7 8.9 13.3 11.9 UNC5CL "MGC34763, ZUD" ENSG00000124602 "Unc-5 family C-terminal like" Q8IV45 6 41026911-41039217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 52.2;kidney: 60.9;liver: 29.9" "Cell line enhanced" "Detected in some" "CACO-2: 8.2;Hep G2: 4.4;RPTEC TERT1: 15.8;U-266/70: 5.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015725 Enhanced Approved Centrosome Centrosome "HPA015725: " "unprognostic (1.10e-2)" "unprognostic (3.59e-2)" "unprognostic (1.60e-1)" "unprognostic (2.57e-1)" "unprognostic (7.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.16e-1)" "unprognostic (8.55e-3)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" "unprognostic (9.30e-2)" "unprognostic (2.35e-1)" "unprognostic (2.31e-1)" "unprognostic (1.19e-1)" "unprognostic (5.60e-6)" 0.4 0.2 0.4 0.6 0.4 0.3 0.5 0.4 0.4 0.4 9.9 0.5 0.4 23.7 0.8 0.8 0.5 0.7 10.2 0.4 0.4 0.1 60.9 29.9 0.9 0.4 0.4 0.4 0.5 17.7 0.1 0.6 0.8 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.6 52.2 0.4 0.4 1.2 15.9 0.6 0.4 0.4 0.7 0.4 0.4 0.4 0.4 0.3 1.0 0.7 0.3 0.0 2.4 0.2 0.6 0.3 0.8 1.1 0.2 0.1 0.7 0.0 0.1 0.0 0.0 8.2 0.1 0.1 3.1 0.0 0.2 0.2 0.3 0.1 1.2 1.6 0.8 0.0 4.4 0.1 0.4 0.3 0.2 0.7 0.0 0.5 0.0 0.6 0.5 0.0 0.2 1.0 2.6 0.3 0.2 1.0 0.1 0.6 15.8 0.0 0.7 0.7 0.0 0.1 1.5 0.2 0.2 0.2 0.0 0.5 0.4 0.1 5.2 2.6 0.7 0.0 1.8 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.2 0.7 0.2 0.1 0.3 0.4 0.0 0.0 0.0 0.3 1.0 2.4 0.2 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 VPS25 "DERP9, EAP20, MGC10540" ENSG00000131475 "Vacuolar protein sorting 25 homolog" Q9BRG1 17 42773436-42779599 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004978, HPA052217, HPA057284" Uncertain Approved Centrosome Centrosome "CAB004978: AB_426095, HPA052217: , HPA057284: " "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.18e-4)" "unprognostic (7.37e-2)" "unprognostic (7.57e-2)" "unprognostic (9.83e-3)" "unprognostic (2.76e-3)" "unprognostic (5.84e-2)" "unprognostic (1.25e-1)" "unprognostic (2.90e-1)" "unprognostic (8.10e-3)" "unprognostic (3.88e-1)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" 18.5 22.8 14.0 16.9 17.4 17.9 26.2 11.0 28.2 21.0 28.8 20.9 23.9 25.3 21.5 32.8 45.9 28.7 22.6 18.0 15.5 12.2 48.7 48.0 17.4 22.0 12.7 15.3 21.7 41.3 28.5 15.7 36.7 17.3 21.3 33.3 27.4 32.6 18.7 24.7 26.0 37.9 20.5 11.3 21.2 25.1 26.6 11.5 32.1 29.2 31.9 37.4 18.7 22.8 19.8 33.2 42.4 35.4 31.0 20.2 22.3 17.3 36.1 27.5 16.6 35.1 24.1 25.6 22.0 31.2 45.4 31.8 30.9 20.5 17.4 37.0 32.1 18.2 37.9 48.2 29.5 15.8 47.7 13.1 23.9 45.7 36.3 24.5 17.5 32.6 31.1 40.2 43.2 28.4 44.7 17.6 27.2 24.9 35.3 27.2 21.2 25.4 13.2 33.3 28.1 54.4 19.9 23.4 18.1 12.4 16.1 33.4 37.1 26.1 15.3 28.9 18.6 16.2 23.5 17.4 9.8 25.3 25.4 16.8 21.2 28.8 32.2 42.4 17.1 35.4 17.4 19.8 18.7 20.2 33.2 17.0 19.1 18.1 18.7 31.0 31.2 22.4 17.1 22.3 14.0 17.4 11.0 28.2 15.5 12.2 12.7 15.3 17.3 11.5 ZNF112 "ZFP112, ZNF228" ENSG00000062370 "Zinc finger protein 112" Q9UJU3 19 44326555-44367217 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023856 Approved Approved Centrosome Centrosome "HPA023856: AB_1859018" "unprognostic (1.99e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "unprognostic (1.04e-1)" "unprognostic (4.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.34e-2)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (2.53e-2)" "unprognostic (1.65e-3)" "prognostic favourable (1.54e-5)" "unprognostic (1.65e-1)" "unprognostic (9.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.57e-3)" 5.7 6.5 9.0 1.7 11.4 0.3 8.0 20.5 10.8 6.3 5.7 6.7 3.2 4.8 7.2 7.4 5.0 7.6 4.4 6.1 9.1 5.5 5.5 3.0 4.6 1.5 12.9 5.8 8.6 5.2 9.1 16.4 4.6 8.1 7.8 5.5 5.2 5.2 7.8 3.8 5.2 4.8 5.4 12.7 3.5 5.8 13.1 13.1 1.0 7.8 4.2 2.8 5.2 6.0 1.6 1.8 0.0 1.7 0.4 0.2 0.3 4.0 2.6 7.3 4.3 4.4 3.9 1.7 3.9 6.5 3.6 5.6 1.7 3.0 0.0 2.8 3.3 3.7 4.3 2.6 5.9 0.0 5.3 4.7 4.2 1.7 3.5 0.0 0.0 4.1 4.8 2.8 5.9 4.3 1.7 11.5 4.3 0.9 0.0 0.0 3.9 1.5 0.0 7.8 2.1 3.5 4.5 3.5 5.7 5.1 1.0 2.7 2.1 0.0 5.9 5.9 4.4 16.8 3.2 0.0 0.0 0.1 3.5 0.0 4.6 0.0 0.4 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.8 1.6 0.0 0.2 0.0 0.4 1.7 0.5 0.0 0.3 9.0 11.4 20.5 10.8 9.1 5.5 12.9 5.8 8.1 13.1 ZNF616 MGC45556 ENSG00000204611 "Zinc finger protein 616" Q08AN1 19 52113091-52139922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA062639, HPA071539" Approved Approved Centrosome Centrosome "HPA062639: , HPA071539: " "unprognostic (5.98e-3)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (2.58e-2)" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (4.78e-3)" "unprognostic (1.97e-1)" "unprognostic (1.19e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (2.60e-1)" "unprognostic (3.01e-2)" "unprognostic (1.32e-3)" 10.5 18.1 9.2 4.9 10.6 2.7 8.6 18.7 10.2 9.1 6.6 6.2 5.6 4.9 9.4 8.6 7.2 9.8 6.0 6.3 8.7 4.8 8.4 8.5 7.6 6.3 12.6 8.1 16.1 10.4 12.7 17.7 9.0 9.1 9.9 8.2 6.1 8.0 11.5 5.4 8.0 6.4 8.0 13.7 7.6 6.7 5.3 10.3 11.9 11.6 4.4 7.2 9.3 12.5 4.7 4.5 4.7 10.9 15.7 6.3 2.5 4.1 3.7 12.5 8.5 15.0 12.3 0.1 5.6 6.6 5.4 8.6 4.2 3.4 5.8 3.9 5.3 2.8 12.9 6.3 8.3 3.9 17.1 10.2 9.6 9.0 8.8 9.8 6.4 8.9 8.9 4.8 17.8 7.3 11.3 2.8 7.8 2.8 9.4 5.1 12.8 11.1 8.3 17.0 8.3 3.9 10.6 12.6 7.0 9.3 4.5 2.9 5.6 3.3 5.9 4.2 5.0 4.7 5.7 5.7 8.4 8.2 3.6 5.8 8.1 3.2 3.5 4.0 6.3 2.3 5.8 3.8 5.8 5.1 3.9 4.7 5.3 4.9 4.7 15.7 10.9 4.5 3.7 2.5 9.2 10.6 18.7 10.2 8.7 4.8 12.6 8.1 9.1 10.3 ZNF620 MGC50836 ENSG00000177842 "Zinc finger protein 620" Q6ZNG0 3 40505992-40518736 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 14.2" "Low lineage specificity" "Detected in all" "HPA031452, HPA059383" Uncertain Approved Centrosome Centrosome "HPA031452: AB_10603939, HPA059383: " "unprognostic (1.42e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-3)" "unprognostic (2.15e-2)" "unprognostic (7.73e-2)" "unprognostic (3.78e-2)" "unprognostic (1.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.21e-5)" "unprognostic (1.28e-1)" "unprognostic (4.78e-1)" "unprognostic (2.61e-2)" "unprognostic (9.19e-4)" 5.8 5.7 5.2 3.0 8.2 8.0 6.1 15.6 8.5 3.7 5.0 8.9 4.8 4.4 4.0 6.3 3.1 5.3 3.2 4.4 5.6 5.7 6.2 4.5 6.2 3.4 10.3 5.8 4.5 8.1 8.7 15.2 6.3 6.4 5.2 5.9 6.1 3.5 5.7 6.3 2.4 4.7 4.3 5.3 5.2 7.3 3.0 7.4 3.7 9.5 3.7 3.1 4.8 4.5 2.0 1.3 14.2 1.0 3.1 3.9 1.2 2.3 3.5 8.4 3.1 0.9 0.9 4.4 0.6 0.9 4.0 5.8 8.2 5.2 0.0 2.6 0.4 0.6 12.4 1.1 2.9 7.1 9.7 6.0 8.7 4.5 1.5 2.1 1.2 0.5 0.8 2.5 1.1 2.7 3.1 1.0 0.5 4.0 0.4 1.8 9.7 1.9 3.2 3.5 1.1 3.7 8.4 9.9 7.5 0.6 5.8 3.8 7.6 2.3 1.8 0.4 5.7 0.8 2.6 1.3 2.1 0.1 1.3 1.2 1.5 14.2 0.6 1.2 2.6 1.0 3.2 0.8 1.0 2.7 0.6 2.0 2.1 2.7 0.9 3.1 0.3 1.3 3.9 1.2 5.2 8.2 15.6 8.5 5.6 5.7 10.3 5.8 6.4 7.4 ZNF766 ENSG00000196214 "Zinc finger protein 766" Q5HY98 19 52269571-52296046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA044882, HPA063496" Uncertain Supported Centrosome Centrosome "HPA044882: AB_10965173, HPA063496: " "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (4.15e-1)" "unprognostic (1.20e-1)" "unprognostic (9.45e-2)" "unprognostic (9.28e-3)" "unprognostic (6.85e-3)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (6.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (2.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.75e-1)" "unprognostic (3.85e-3)" 11.9 9.9 9.0 10.5 13.7 16.5 14.9 12.3 13.7 13.1 10.8 8.9 13.1 7.3 12.3 9.8 12.4 11.9 7.7 9.6 8.5 7.3 10.2 7.0 10.2 13.7 13.0 7.3 18.4 10.9 12.6 23.5 11.9 12.8 14.4 10.1 9.9 11.6 12.1 11.3 13.8 10.1 13.7 14.9 14.2 9.7 26.4 13.7 17.5 17.1 7.2 12.9 18.1 11.0 18.8 8.7 22.5 12.1 18.1 27.6 11.5 6.9 11.3 8.2 9.7 8.5 12.3 6.2 6.9 6.6 4.4 8.8 3.0 5.6 11.5 6.4 7.1 7.0 7.8 6.7 7.9 8.9 10.7 11.9 6.6 3.3 5.0 13.2 8.1 9.6 9.8 5.1 12.1 6.8 7.8 6.6 7.7 4.7 17.4 5.7 9.6 12.6 12.1 14.6 10.1 5.7 20.3 10.4 8.7 10.4 8.2 5.8 9.6 7.9 8.2 4.2 5.9 3.7 7.1 11.2 32.3 17.4 4.0 6.9 8.0 22.5 8.6 16.6 16.1 12.1 22.2 18.8 17.5 18.2 8.7 16.2 27.6 21.6 9.2 18.1 12.0 6.1 17.9 11.5 9.0 13.7 12.3 13.7 8.5 7.3 13.0 7.3 12.8 13.7